Gene Symbol | Gene ID | Gene Info |
---|---|---|
Dlx1
|
ENSMUSG00000041911.3 | distal-less homeobox 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_71528185_71528427 | Dlx1 | 193 | 0.692073 | -0.83 | 5.1e-15 | Click! |
chr2_71528496_71528675 | Dlx1 | 98 | 0.893962 | -0.79 | 8.7e-13 | Click! |
chr2_71528837_71529004 | Dlx1 | 181 | 0.879266 | -0.67 | 2.1e-08 | Click! |
chr2_71534073_71534224 | Dlx1 | 3368 | 0.164765 | -0.67 | 2.8e-08 | Click! |
chr2_71529017_71529497 | Dlx1 | 156 | 0.912051 | -0.63 | 2.0e-07 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_138424907_138425582 | 48.47 |
Lmo3 |
LIM domain only 3 |
629 |
0.69 |
chr5_33542035_33542598 | 42.79 |
Fam53a |
family with sequence similarity 53, member A |
86596 |
0.05 |
chr7_109191268_109192295 | 39.76 |
Lmo1 |
LIM domain only 1 |
16574 |
0.17 |
chr17_47909349_47909983 | 38.31 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr15_79690079_79691459 | 34.53 |
Gtpbp1 |
GTP binding protein 1 |
76 |
0.92 |
chr5_112001700_112002600 | 33.18 |
Gm42488 |
predicted gene 42488 |
57915 |
0.13 |
chr16_72699156_72700074 | 30.90 |
Robo1 |
roundabout guidance receptor 1 |
36411 |
0.24 |
chr1_80408527_80409167 | 30.89 |
Gm6189 |
predicted gene 6189 |
23662 |
0.13 |
chr6_146981244_146981874 | 30.46 |
Ppfibp1 |
PTPRF interacting protein, binding protein 1 (liprin beta 1) |
5076 |
0.15 |
chr7_109174643_109175577 | 29.27 |
Lmo1 |
LIM domain only 1 |
97 |
0.97 |
chr13_85126661_85127037 | 28.66 |
Gm4076 |
predicted gene 4076 |
665 |
0.69 |
chr1_24612739_24612914 | 28.18 |
Gm10222 |
predicted gene 10222 |
126 |
0.59 |
chrX_123721926_123722462 | 27.39 |
Rps12-ps23 |
ribosomal protein S12, pseudogene 23 |
13617 |
0.18 |
chrX_123943434_123943951 | 27.16 |
Rps12-ps20 |
ribosomal protein S12, pseudogene 20 |
13582 |
0.23 |
chr1_12409934_12410455 | 26.59 |
Mir6341 |
microRNA 6341 |
15792 |
0.23 |
chrX_123271195_123271712 | 26.54 |
Rps12-ps21 |
ribosomal protein S12, pseudogene 22 |
13591 |
0.15 |
chrX_123500550_123501093 | 26.27 |
Rps12-ps22 |
ribosomal protein S12, pseudogene 22 |
13606 |
0.18 |
chr3_144198270_144199266 | 24.12 |
Gm43445 |
predicted gene 43445 |
494 |
0.79 |
chr2_105769867_105770156 | 23.92 |
Elp4 |
elongator acetyltransferase complex subunit 4 |
44311 |
0.13 |
chr4_83206835_83207691 | 23.72 |
Gm11185 |
predicted gene 11185 |
13275 |
0.19 |
chr3_157732464_157732921 | 23.12 |
Gm33466 |
predicted gene, 33466 |
6284 |
0.26 |
chr11_113014293_113014953 | 22.52 |
2610035D17Rik |
RIKEN cDNA 2610035D17 gene |
158454 |
0.04 |
chr3_144174293_144174609 | 21.16 |
Lmo4 |
LIM domain only 4 |
20367 |
0.17 |
chr13_97825475_97826241 | 20.58 |
Gm41031 |
predicted gene, 41031 |
27 |
0.98 |
chr1_162216776_162217075 | 19.72 |
Dnm3os |
dynamin 3, opposite strand |
698 |
0.48 |
chr5_60042722_60043044 | 19.34 |
Gm43393 |
predicted gene 43393 |
17000 |
0.17 |
chr11_48855844_48857180 | 18.85 |
Gm16170 |
predicted gene 16170 |
3019 |
0.13 |
chr13_77548432_77549057 | 18.79 |
Gm9634 |
predicted gene 9634 |
5629 |
0.31 |
chr14_48418768_48419083 | 18.20 |
Gm3534 |
predicted pseudogene 3534 |
10307 |
0.15 |
chr18_35848127_35849279 | 18.14 |
Cxxc5 |
CXXC finger 5 |
5984 |
0.11 |
chr18_42510920_42511513 | 17.46 |
Tcerg1 |
transcription elongation regulator 1 (CA150) |
271 |
0.91 |
chr6_42363179_42363495 | 17.02 |
2010310C07Rik |
RIKEN cDNA 2010310C07 gene |
7334 |
0.09 |
chr6_98767823_98768513 | 16.34 |
Gm32308 |
predicted gene, 32308 |
10419 |
0.26 |
chr6_138582721_138582913 | 16.30 |
Lmo3 |
LIM domain only 3 |
849 |
0.56 |
chr8_108703603_108704102 | 16.04 |
Zfhx3 |
zinc finger homeobox 3 |
752 |
0.73 |
chr11_79961869_79962916 | 16.02 |
Utp6 |
UTP6 small subunit processome component |
2 |
0.97 |
chr8_120549369_120550473 | 15.94 |
Mir7687 |
microRNA 7687 |
11225 |
0.1 |
chr8_91331323_91331874 | 15.60 |
Fto |
fat mass and obesity associated |
17984 |
0.13 |
chr8_122329580_122330425 | 15.57 |
Zfpm1 |
zinc finger protein, multitype 1 |
3696 |
0.15 |
chrX_133653163_133653401 | 15.35 |
Pcdh19 |
protocadherin 19 |
31709 |
0.23 |
chr6_9834968_9835442 | 15.31 |
Gm5110 |
predicted gene 5110 |
337649 |
0.01 |
chr1_68666889_68667107 | 15.12 |
Gm37735 |
predicted gene, 37735 |
26169 |
0.2 |
chr8_128688649_128689204 | 15.11 |
Itgb1 |
integrin beta 1 (fibronectin receptor beta) |
3056 |
0.24 |
chr13_25392857_25393350 | 15.10 |
F830002E08Rik |
RIKEN cDNA F830002E08 gene |
37024 |
0.18 |
chr8_66363123_66363725 | 15.10 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
22870 |
0.19 |
chr14_76817069_76817629 | 15.04 |
Gm48968 |
predicted gene, 48968 |
15472 |
0.18 |
chr11_49713043_49713524 | 14.79 |
Cnot6 |
CCR4-NOT transcription complex, subunit 6 |
560 |
0.67 |
chr12_79674954_79675872 | 14.45 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
249320 |
0.02 |
chr2_22587496_22588353 | 14.07 |
Gm13341 |
predicted gene 13341 |
38 |
0.95 |
chr18_87921786_87922162 | 14.07 |
Gm24987 |
predicted gene, 24987 |
3590 |
0.34 |
chr1_85259970_85261058 | 14.03 |
C130026I21Rik |
RIKEN cDNA C130026I21 gene |
1556 |
0.27 |
chr11_100938783_100940230 | 14.03 |
Stat3 |
signal transducer and activator of transcription 3 |
27 |
0.97 |
chr9_61370339_61371660 | 14.02 |
Gm10655 |
predicted gene 10655 |
628 |
0.63 |
chr1_24613351_24614205 | 13.96 |
Gm28437 |
predicted gene 28437 |
193 |
0.69 |
chr4_80002679_80002838 | 13.93 |
Gm11407 |
predicted gene 11407 |
427 |
0.69 |
chr16_11316044_11316195 | 13.84 |
Tnfrsf17 |
tumor necrosis factor receptor superfamily, member 17 |
2307 |
0.25 |
chr9_108338578_108339700 | 13.83 |
Gpx1 |
glutathione peroxidase 1 |
85 |
0.89 |
chr13_11836412_11836699 | 13.46 |
Ryr2 |
ryanodine receptor 2, cardiac |
6901 |
0.24 |
chr5_121889411_121889760 | 13.45 |
Cux2 |
cut-like homeobox 2 |
5796 |
0.15 |
chr5_116023179_116023683 | 13.35 |
Prkab1 |
protein kinase, AMP-activated, beta 1 non-catalytic subunit |
925 |
0.45 |
chr8_36668721_36669167 | 13.27 |
Dlc1 |
deleted in liver cancer 1 |
55001 |
0.16 |
chr3_79144987_79146081 | 13.26 |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
341 |
0.91 |
chr12_72437630_72438246 | 13.05 |
Lrrc9 |
leucine rich repeat containing 9 |
3928 |
0.24 |
chr8_20817574_20818579 | 13.02 |
Gm20946 |
predicted gene, 20946 |
10277 |
0.15 |
chr6_55901966_55902527 | 12.97 |
Itprid1 |
ITPR interacting domain containing 1 |
15421 |
0.27 |
chr5_139681780_139682442 | 12.86 |
Gm42424 |
predicted gene 42424 |
19536 |
0.16 |
chr13_52822783_52823147 | 12.76 |
BB123696 |
expressed sequence BB123696 |
65760 |
0.12 |
chr16_26041382_26041987 | 12.75 |
AU015336 |
expressed sequence AU015336 |
416 |
0.88 |
chr8_110987902_110988088 | 12.59 |
Ddx19a |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 19a |
7361 |
0.11 |
chr4_154121558_154121709 | 12.55 |
Trp73 |
transformation related protein 73 |
5028 |
0.13 |
chr3_34504199_34504577 | 12.47 |
Gm29135 |
predicted gene 29135 |
22181 |
0.16 |
chr5_137786077_137787112 | 12.25 |
Mepce |
methylphosphate capping enzyme |
69 |
0.92 |
chr3_55075221_55075624 | 12.19 |
Gm43555 |
predicted gene 43555 |
17766 |
0.13 |
chr1_64087943_64089121 | 12.15 |
Gm13748 |
predicted gene 13748 |
9878 |
0.19 |
chr13_91890302_91890496 | 12.12 |
Ckmt2 |
creatine kinase, mitochondrial 2 |
13514 |
0.2 |
chr9_103288790_103289055 | 12.07 |
1300017J02Rik |
RIKEN cDNA 1300017J02 gene |
625 |
0.69 |
chr10_21295422_21295685 | 12.05 |
Hbs1l |
Hbs1-like (S. cerevisiae) |
426 |
0.79 |
chr17_47914586_47915244 | 12.03 |
Gm15556 |
predicted gene 15556 |
7463 |
0.14 |
chr14_8286642_8286923 | 12.00 |
Fam107a |
family with sequence similarity 107, member A |
22995 |
0.16 |
chr6_72279340_72279553 | 11.97 |
Sftpb |
surfactant associated protein B |
25164 |
0.11 |
chr7_40842646_40842992 | 11.96 |
Gm45008 |
predicted gene 45008 |
21709 |
0.13 |
chr3_103171228_103172264 | 11.90 |
Bcas2 |
breast carcinoma amplified sequence 2 |
3 |
0.97 |
chr19_43767999_43768210 | 11.82 |
Cutc |
cutC copper transporter |
3231 |
0.18 |
chr3_127930721_127931028 | 11.80 |
9830132P13Rik |
RIKEN cDNA 9830132P13 gene |
14702 |
0.14 |
chr18_60605971_60606545 | 11.75 |
Synpo |
synaptopodin |
3847 |
0.19 |
chr13_80695725_80695888 | 11.74 |
Arrdc3 |
arrestin domain containing 3 |
187578 |
0.03 |
chr15_99651541_99652191 | 11.65 |
Racgap1 |
Rac GTPase-activating protein 1 |
210 |
0.88 |
chr3_121291927_121292619 | 11.64 |
Alg14 |
asparagine-linked glycosylation 14 |
383 |
0.82 |
chr5_137349031_137350198 | 11.55 |
Ephb4 |
Eph receptor B4 |
495 |
0.62 |
chr1_105088844_105089211 | 11.53 |
Gm29012 |
predicted gene 29012 |
27427 |
0.23 |
chr13_84515013_84515539 | 11.48 |
Gm26927 |
predicted gene, 26927 |
175163 |
0.03 |
chr4_116720426_116721428 | 11.47 |
Tesk2 |
testis-specific kinase 2 |
21 |
0.96 |
chr1_21660699_21661216 | 11.46 |
Gm7658 |
predicted gene 7658 |
147901 |
0.04 |
chr1_86479174_86479713 | 11.45 |
Rpl30-ps6 |
ribosomal protein L30, pseudogene 6 |
5784 |
0.15 |
chr1_85099723_85100032 | 11.41 |
Gm10553 |
predicted gene 10553 |
287 |
0.81 |
chr15_96874188_96874389 | 11.37 |
Rpl10a-ps3 |
ribosomal protein L10A, pseudogene 3 |
49117 |
0.16 |
chr16_76319178_76320114 | 11.31 |
Nrip1 |
nuclear receptor interacting protein 1 |
4012 |
0.29 |
chr3_29136074_29136608 | 11.31 |
Gm38029 |
predicted gene, 38029 |
38497 |
0.17 |
chr7_143340680_143341191 | 11.29 |
Gm38095 |
predicted gene, 38095 |
3502 |
0.17 |
chr7_133988507_133988680 | 11.28 |
Adam12 |
a disintegrin and metallopeptidase domain 12 (meltrin alpha) |
27328 |
0.2 |
chr3_79841487_79841829 | 11.19 |
Tmem144 |
transmembrane protein 144 |
71 |
0.97 |
chr3_96251008_96251159 | 11.14 |
Gm20627 |
predicted gene 20627 |
4386 |
0.04 |
chr9_88483752_88484150 | 11.10 |
Syncrip |
synaptotagmin binding, cytoplasmic RNA interacting protein |
1377 |
0.28 |
chr5_92404066_92404450 | 11.08 |
Art3 |
ADP-ribosyltransferase 3 |
2260 |
0.19 |
chr1_166002288_166003185 | 11.00 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
58 |
0.72 |
chr13_16023381_16024064 | 10.97 |
B230303A05Rik |
RIKEN cDNA B230303A05 gene |
299 |
0.86 |
chr9_47279937_47280178 | 10.83 |
Gm31816 |
predicted gene, 31816 |
9314 |
0.26 |
chr5_137530580_137532081 | 10.66 |
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
33 |
0.9 |
chr14_33687535_33688054 | 10.63 |
Gm26228 |
predicted gene, 26228 |
43299 |
0.14 |
chr2_17510016_17510384 | 10.56 |
Nebl |
nebulette |
18124 |
0.22 |
chr19_7605885_7606822 | 10.52 |
Lgals12 |
lectin, galactose binding, soluble 12 |
750 |
0.59 |
chr17_36121540_36121726 | 10.51 |
Gm19684 |
predicted gene, 19684 |
45 |
0.63 |
chr2_136148933_136149455 | 10.50 |
Gm14218 |
predicted gene 14218 |
12188 |
0.26 |
chr10_105423144_105423438 | 10.49 |
Gm48203 |
predicted gene, 48203 |
29005 |
0.15 |
chr11_19455976_19456277 | 10.48 |
Gm12026 |
predicted gene 12026 |
72441 |
0.11 |
chr10_127508848_127510720 | 10.48 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr7_125112792_125113319 | 10.42 |
Glud-ps |
glutamate dehydrogenase, pseudogene |
37704 |
0.17 |
chr12_41351050_41351632 | 10.37 |
Gm25497 |
predicted gene, 25497 |
2769 |
0.25 |
chr6_52190902_52191308 | 10.25 |
Hoxa4 |
homeobox A4 |
648 |
0.36 |
chr10_63199151_63199302 | 10.19 |
Mypn |
myopalladin |
4726 |
0.16 |
chr7_29070679_29071390 | 10.19 |
Gm26604 |
predicted gene, 26604 |
569 |
0.5 |
chr12_24746783_24747204 | 10.18 |
Gm48895 |
predicted gene, 48895 |
13232 |
0.11 |
chr14_52103963_52104507 | 10.18 |
Hnrnpc |
heterogeneous nuclear ribonucleoprotein C |
207 |
0.88 |
chr1_77505970_77506663 | 10.18 |
Epha4 |
Eph receptor A4 |
8763 |
0.19 |
chr13_43231981_43232458 | 10.06 |
Tbc1d7 |
TBC1 domain family, member 7 |
60718 |
0.11 |
chr4_117682587_117682738 | 10.06 |
Dmap1 |
DNA methyltransferase 1-associated protein 1 |
389 |
0.81 |
chr18_3005171_3005609 | 10.02 |
Gm50072 |
predicted gene, 50072 |
10518 |
0.21 |
chr1_126391091_126391421 | 10.00 |
Nckap5 |
NCK-associated protein 5 |
57200 |
0.15 |
chr1_85112673_85113075 | 9.98 |
A530040E14Rik |
RIKEN cDNA A530040E14 gene |
1062 |
0.3 |
chr9_66181229_66181417 | 9.92 |
Dapk2 |
death-associated protein kinase 2 |
23088 |
0.17 |
chr3_108562098_108562631 | 9.92 |
Tmem167b |
transmembrane protein 167B |
102 |
0.92 |
chr14_48445875_48446199 | 9.90 |
Tmem260 |
transmembrane protein 260 |
87 |
0.96 |
chr11_35572283_35572434 | 9.88 |
Slit3 |
slit guidance ligand 3 |
27673 |
0.2 |
chr10_20046153_20046446 | 9.83 |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
53226 |
0.13 |
chr12_29698179_29698919 | 9.81 |
C630031E19Rik |
RIKEN cDNA C630031E19 gene |
12104 |
0.29 |
chr3_5224662_5225307 | 9.76 |
Zfhx4 |
zinc finger homeodomain 4 |
3479 |
0.23 |
chr6_136858196_136858347 | 9.76 |
Art4 |
ADP-ribosyltransferase 4 |
538 |
0.6 |
chr13_104285003_104285221 | 9.76 |
Adamts6 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 6 |
2723 |
0.29 |
chr3_27751571_27751754 | 9.70 |
Fndc3b |
fibronectin type III domain containing 3B |
40355 |
0.19 |
chr4_75212425_75212866 | 9.67 |
Gm12912 |
predicted gene 12912 |
65036 |
0.1 |
chr7_5060805_5061447 | 9.62 |
Gm45133 |
predicted gene 45133 |
923 |
0.22 |
chr5_111836465_111837021 | 9.59 |
Gm36535 |
predicted gene, 36535 |
43356 |
0.15 |
chr1_51893797_51894181 | 9.47 |
Myo1b |
myosin IB |
2312 |
0.23 |
chr5_139099227_139099378 | 9.47 |
Prkar1b |
protein kinase, cAMP dependent regulatory, type I beta |
13342 |
0.18 |
chr1_168268952_168269254 | 9.46 |
Gm37524 |
predicted gene, 37524 |
68568 |
0.12 |
chr4_155213419_155213944 | 9.46 |
Ski |
ski sarcoma viral oncogene homolog (avian) |
8854 |
0.18 |
chr8_94898997_94899206 | 9.44 |
Ccdc102a |
coiled-coil domain containing 102A |
18420 |
0.1 |
chr13_64155195_64155660 | 9.44 |
Zfp367 |
zinc finger protein 367 |
2225 |
0.18 |
chr2_139724299_139724734 | 9.43 |
Ism1 |
isthmin 1, angiogenesis inhibitor |
46338 |
0.15 |
chr7_108797287_108797500 | 9.40 |
Gm45232 |
predicted gene 45232 |
2390 |
0.19 |
chr1_184781740_184782518 | 9.40 |
Mtarc1 |
mitochondrial amidoxime reducing component 1 |
26724 |
0.12 |
chr16_55816469_55816872 | 9.39 |
Nfkbiz |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, zeta |
1845 |
0.33 |
chr2_12019857_12020050 | 9.38 |
Gm13310 |
predicted gene 13310 |
64039 |
0.11 |
chr2_155604522_155604830 | 9.37 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
6536 |
0.08 |
chr6_52163698_52164573 | 9.36 |
Hoxa2 |
homeobox A2 |
696 |
0.33 |
chr12_46635290_46635769 | 9.35 |
Gm48535 |
predicted gene, 48535 |
30180 |
0.15 |
chr4_134165911_134166062 | 9.35 |
Gm27619 |
predicted gene, 27619 |
1909 |
0.19 |
chr11_103132227_103133103 | 9.33 |
Hexim2 |
hexamethylene bis-acetamide inducible 2 |
236 |
0.88 |
chr7_126975552_126976438 | 9.32 |
Cdiptos |
CDIP transferase, opposite strand |
57 |
0.51 |
chr11_30648868_30649937 | 9.30 |
Acyp2 |
acylphosphatase 2, muscle type |
185 |
0.95 |
chr1_34389196_34389610 | 9.27 |
Gm5266 |
predicted gene 5266 |
22032 |
0.09 |
chr12_83044271_83044926 | 9.23 |
Rgs6 |
regulator of G-protein signaling 6 |
2392 |
0.32 |
chr13_43480925_43481874 | 9.22 |
Ranbp9 |
RAN binding protein 9 |
117 |
0.95 |
chr15_77773478_77773629 | 9.21 |
Myh9 |
myosin, heavy polypeptide 9, non-muscle |
3774 |
0.14 |
chr1_66862302_66862580 | 9.17 |
Acadl |
acyl-Coenzyme A dehydrogenase, long-chain |
836 |
0.42 |
chr11_46699039_46699190 | 9.17 |
Timd2 |
T cell immunoglobulin and mucin domain containing 2 |
152 |
0.94 |
chr11_35286693_35287107 | 9.15 |
Gm12123 |
predicted gene 12123 |
36770 |
0.18 |
chr9_65196833_65197269 | 9.13 |
Gm25313 |
predicted gene, 25313 |
364 |
0.76 |
chr1_67193921_67194072 | 9.12 |
Gm15668 |
predicted gene 15668 |
55204 |
0.12 |
chr11_115911570_115911751 | 9.12 |
Smim6 |
small integral membrane protein 6 |
357 |
0.74 |
chr1_78203643_78204022 | 9.10 |
Pax3 |
paired box 3 |
6698 |
0.23 |
chr11_87368253_87368600 | 9.09 |
Ppm1e |
protein phosphatase 1E (PP2C domain containing) |
9403 |
0.12 |
chr5_115235264_115235764 | 9.04 |
Pop5 |
processing of precursor 5, ribonuclease P/MRP family (S. cerevisiae) |
322 |
0.78 |
chr19_53080891_53081464 | 9.01 |
1700054A03Rik |
RIKEN cDNA 1700054A03 gene |
400 |
0.83 |
chr7_4739300_4740219 | 9.00 |
Kmt5c |
lysine methyltransferase 5C |
356 |
0.63 |
chr12_111008305_111008501 | 8.97 |
Gm48631 |
predicted gene, 48631 |
9999 |
0.11 |
chr3_116366245_116366396 | 8.95 |
Gm29151 |
predicted gene 29151 |
16217 |
0.16 |
chr1_132190710_132192438 | 8.93 |
Gm29695 |
predicted gene, 29695 |
117 |
0.49 |
chr19_4387351_4387502 | 8.90 |
Kdm2a |
lysine (K)-specific demethylase 2A |
9491 |
0.13 |
chr4_132075006_132075723 | 8.90 |
Epb41 |
erythrocyte membrane protein band 4.1 |
43 |
0.91 |
chr5_115436438_115437458 | 8.80 |
4930430O22Rik |
RIKEN cDNA 4930430O22 gene |
304 |
0.74 |
chr17_35741597_35741789 | 8.78 |
Gm20443 |
predicted gene 20443 |
1887 |
0.16 |
chr1_67186231_67186382 | 8.77 |
Gm15668 |
predicted gene 15668 |
62894 |
0.11 |
chr13_95525489_95525667 | 8.74 |
F2rl1 |
coagulation factor II (thrombin) receptor-like 1 |
351 |
0.85 |
chr13_23697544_23698095 | 8.73 |
H4c3 |
H4 clustered histone 3 |
635 |
0.35 |
chr17_23684213_23684592 | 8.72 |
Cldn9 |
claudin 9 |
376 |
0.62 |
chr19_55938421_55938984 | 8.67 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
40393 |
0.17 |
chr8_18991275_18991446 | 8.67 |
Defb37 |
defensin beta 37 |
305 |
0.84 |
chr18_3616214_3616807 | 8.65 |
Gm50091 |
predicted gene, 50091 |
229 |
0.95 |
chr7_142658735_142659435 | 8.62 |
Igf2 |
insulin-like growth factor 2 |
404 |
0.55 |
chr18_50133862_50134181 | 8.59 |
Cd63-ps |
CD63 antigen, pseudogene |
705 |
0.67 |
chr3_6887007_6887616 | 8.58 |
Gm22074 |
predicted gene, 22074 |
89957 |
0.09 |
chr15_96455910_96456125 | 8.57 |
Scaf11 |
SR-related CTD-associated factor 11 |
4783 |
0.23 |
chr4_45453233_45453615 | 8.53 |
Shb |
src homology 2 domain-containing transforming protein B |
29378 |
0.12 |
chr5_67400952_67401103 | 8.51 |
Bend4 |
BEN domain containing 4 |
26303 |
0.11 |
chr1_184290010_184290162 | 8.49 |
Gm37223 |
predicted gene, 37223 |
68243 |
0.11 |
chr5_148897060_148897772 | 8.48 |
Katnal1 |
katanin p60 subunit A-like 1 |
18337 |
0.11 |
chr16_95382153_95382455 | 8.47 |
Gm31641 |
predicted gene, 31641 |
26628 |
0.2 |
chr17_83659006_83659302 | 8.37 |
Kcng3 |
potassium voltage-gated channel, subfamily G, member 3 |
27259 |
0.19 |
chr12_103737920_103738559 | 8.37 |
Serpina1b |
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
81 |
0.95 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.0 | 36.1 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
4.9 | 14.6 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
4.5 | 13.6 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
4.4 | 13.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
3.9 | 11.8 | GO:0040031 | snRNA modification(GO:0040031) |
3.9 | 11.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
3.3 | 10.0 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
3.2 | 9.7 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
3.2 | 9.6 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
3.1 | 3.1 | GO:0070672 | response to interleukin-15(GO:0070672) |
3.0 | 9.1 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
3.0 | 8.9 | GO:0048769 | sarcomerogenesis(GO:0048769) |
3.0 | 5.9 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
2.9 | 11.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
2.8 | 8.5 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
2.8 | 5.5 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
2.8 | 11.0 | GO:0006742 | NADP catabolic process(GO:0006742) |
2.8 | 5.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
2.7 | 2.7 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
2.5 | 15.2 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
2.4 | 7.1 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
2.4 | 2.4 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
2.4 | 7.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
2.3 | 7.0 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
2.3 | 7.0 | GO:0021553 | olfactory nerve development(GO:0021553) |
2.3 | 6.8 | GO:1990928 | response to amino acid starvation(GO:1990928) |
2.2 | 6.6 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
2.2 | 13.0 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
2.1 | 6.4 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
2.1 | 10.6 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
2.1 | 8.4 | GO:0021569 | rhombomere 3 development(GO:0021569) |
2.1 | 8.4 | GO:0007296 | vitellogenesis(GO:0007296) |
2.0 | 4.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
2.0 | 6.0 | GO:0008050 | female courtship behavior(GO:0008050) |
2.0 | 6.0 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
2.0 | 6.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
2.0 | 3.9 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
2.0 | 11.8 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
1.9 | 9.5 | GO:0009249 | protein lipoylation(GO:0009249) |
1.9 | 5.7 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
1.9 | 5.7 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
1.9 | 5.6 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.8 | 11.1 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
1.8 | 3.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.8 | 44.0 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.8 | 5.5 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.8 | 7.2 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
1.8 | 5.4 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
1.8 | 7.2 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
1.7 | 5.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.7 | 3.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.7 | 5.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
1.7 | 20.2 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
1.7 | 6.7 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
1.7 | 6.6 | GO:0021590 | cerebellum maturation(GO:0021590) |
1.7 | 6.6 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.6 | 8.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.6 | 6.5 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
1.6 | 1.6 | GO:0097503 | sialylation(GO:0097503) |
1.6 | 4.8 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.6 | 6.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.6 | 1.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.6 | 11.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
1.6 | 6.3 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
1.6 | 4.7 | GO:0000087 | mitotic M phase(GO:0000087) |
1.6 | 6.2 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
1.6 | 4.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.5 | 7.7 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
1.5 | 4.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.5 | 3.0 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
1.5 | 4.6 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
1.5 | 10.6 | GO:0060613 | fat pad development(GO:0060613) |
1.5 | 6.0 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
1.5 | 5.9 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
1.5 | 3.0 | GO:0045472 | response to ether(GO:0045472) |
1.5 | 13.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.5 | 4.4 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
1.5 | 5.9 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.5 | 4.4 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.4 | 1.4 | GO:1904673 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) |
1.4 | 7.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.4 | 8.6 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.4 | 4.3 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.4 | 7.1 | GO:0046618 | drug export(GO:0046618) |
1.4 | 4.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.4 | 4.2 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
1.4 | 11.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
1.4 | 2.8 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
1.4 | 4.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.4 | 5.5 | GO:0008228 | opsonization(GO:0008228) |
1.4 | 4.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.4 | 4.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.4 | 4.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.3 | 2.7 | GO:0003166 | bundle of His development(GO:0003166) |
1.3 | 6.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.3 | 5.3 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
1.3 | 6.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.3 | 6.6 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.3 | 1.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.3 | 2.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.3 | 1.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
1.3 | 1.3 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
1.3 | 6.5 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
1.3 | 5.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.3 | 5.1 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
1.3 | 3.8 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
1.3 | 3.8 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
1.3 | 3.8 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
1.3 | 3.8 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
1.3 | 5.1 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.3 | 7.6 | GO:0015871 | choline transport(GO:0015871) |
1.3 | 3.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.3 | 3.8 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
1.3 | 5.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.3 | 3.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.2 | 5.0 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.2 | 5.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
1.2 | 4.9 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.2 | 2.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.2 | 1.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.2 | 3.7 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
1.2 | 7.3 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
1.2 | 4.9 | GO:1900200 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
1.2 | 3.7 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.2 | 14.6 | GO:0097286 | iron ion import(GO:0097286) |
1.2 | 4.9 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.2 | 8.5 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
1.2 | 18.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
1.2 | 3.6 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.2 | 5.9 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
1.2 | 4.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.2 | 19.0 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
1.2 | 3.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.2 | 2.4 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
1.2 | 3.5 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
1.2 | 4.7 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
1.2 | 4.7 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
1.2 | 2.3 | GO:0002432 | granuloma formation(GO:0002432) |
1.2 | 2.3 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
1.2 | 11.6 | GO:0016540 | protein autoprocessing(GO:0016540) |
1.2 | 7.0 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
1.1 | 1.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
1.1 | 3.4 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
1.1 | 2.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.1 | 5.7 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
1.1 | 1.1 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
1.1 | 6.8 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
1.1 | 10.1 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
1.1 | 6.7 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
1.1 | 2.2 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.1 | 2.2 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
1.1 | 2.2 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
1.1 | 1.1 | GO:0044027 | DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
1.1 | 7.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.1 | 3.3 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.1 | 3.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
1.1 | 5.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.1 | 4.3 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.1 | 3.2 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
1.1 | 5.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.1 | 2.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.1 | 7.4 | GO:0060539 | diaphragm development(GO:0060539) |
1.1 | 3.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
1.1 | 2.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.1 | 3.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
1.0 | 3.1 | GO:0032439 | endosome localization(GO:0032439) |
1.0 | 1.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
1.0 | 3.1 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
1.0 | 17.7 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
1.0 | 4.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.0 | 2.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.0 | 5.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.0 | 1.0 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
1.0 | 10.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
1.0 | 6.1 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.0 | 3.0 | GO:0015744 | succinate transport(GO:0015744) |
1.0 | 3.0 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.0 | 2.0 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.0 | 5.0 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
1.0 | 17.9 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
1.0 | 1.0 | GO:0006573 | valine metabolic process(GO:0006573) |
1.0 | 2.0 | GO:0035493 | SNARE complex assembly(GO:0035493) |
1.0 | 1.0 | GO:0060065 | uterus development(GO:0060065) |
1.0 | 3.9 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
1.0 | 4.9 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
1.0 | 2.9 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.0 | 1.0 | GO:0010159 | specification of organ position(GO:0010159) |
1.0 | 2.9 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
1.0 | 5.8 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.0 | 2.9 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
1.0 | 3.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.0 | 3.8 | GO:0003383 | apical constriction(GO:0003383) |
1.0 | 1.0 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.9 | 1.9 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.9 | 2.8 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.9 | 1.9 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.9 | 12.1 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.9 | 2.8 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.9 | 2.7 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.9 | 10.0 | GO:0007614 | short-term memory(GO:0007614) |
0.9 | 6.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.9 | 0.9 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.9 | 0.9 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.9 | 3.6 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.9 | 16.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.9 | 2.7 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.9 | 13.4 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.9 | 6.3 | GO:0051195 | negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.9 | 5.4 | GO:0015671 | oxygen transport(GO:0015671) |
0.9 | 3.6 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.9 | 2.7 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.9 | 0.9 | GO:0070384 | Harderian gland development(GO:0070384) |
0.9 | 9.7 | GO:0019985 | translesion synthesis(GO:0019985) |
0.9 | 0.9 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.9 | 4.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.9 | 1.8 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.9 | 0.9 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.9 | 4.4 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.9 | 2.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.9 | 8.6 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.9 | 12.0 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.9 | 1.7 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.8 | 5.9 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.8 | 33.8 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.8 | 1.7 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.8 | 0.8 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.8 | 1.7 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.8 | 2.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.8 | 5.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.8 | 3.4 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.8 | 4.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.8 | 2.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.8 | 2.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.8 | 0.8 | GO:0050904 | diapedesis(GO:0050904) |
0.8 | 3.3 | GO:0051031 | tRNA transport(GO:0051031) |
0.8 | 14.9 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.8 | 3.3 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.8 | 1.7 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.8 | 2.5 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.8 | 6.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.8 | 3.3 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.8 | 0.8 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
0.8 | 2.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.8 | 3.2 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.8 | 3.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.8 | 4.0 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.8 | 2.4 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.8 | 3.2 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.8 | 8.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.8 | 8.0 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.8 | 4.8 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.8 | 2.4 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.8 | 0.8 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.8 | 6.3 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.8 | 9.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.8 | 3.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.8 | 7.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.8 | 3.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.8 | 16.4 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.8 | 1.6 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.8 | 2.3 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.8 | 1.6 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.8 | 0.8 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.8 | 0.8 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.8 | 1.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.8 | 2.3 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.8 | 1.5 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.8 | 0.8 | GO:0061055 | myotome development(GO:0061055) |
0.8 | 6.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.8 | 2.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.8 | 5.4 | GO:0007343 | egg activation(GO:0007343) |
0.8 | 7.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.8 | 0.8 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.8 | 0.8 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.8 | 0.8 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.8 | 6.8 | GO:0070269 | pyroptosis(GO:0070269) |
0.8 | 0.8 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.8 | 0.8 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.8 | 3.8 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.7 | 3.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.7 | 2.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.7 | 1.5 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.7 | 2.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.7 | 2.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.7 | 4.4 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.7 | 3.0 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.7 | 8.1 | GO:0006301 | postreplication repair(GO:0006301) |
0.7 | 2.2 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.7 | 2.9 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.7 | 1.5 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.7 | 2.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.7 | 2.9 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.7 | 0.7 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.7 | 2.2 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.7 | 2.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.7 | 3.6 | GO:0060023 | soft palate development(GO:0060023) |
0.7 | 3.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.7 | 1.4 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.7 | 0.7 | GO:0048254 | snoRNA localization(GO:0048254) |
0.7 | 1.4 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.7 | 2.1 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.7 | 3.5 | GO:0001776 | leukocyte homeostasis(GO:0001776) |
0.7 | 2.1 | GO:0032898 | neurotrophin production(GO:0032898) |
0.7 | 1.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.7 | 1.4 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.7 | 1.4 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.7 | 3.5 | GO:0009642 | response to light intensity(GO:0009642) |
0.7 | 0.7 | GO:0035799 | ureter maturation(GO:0035799) |
0.7 | 2.8 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.7 | 2.1 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.7 | 2.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.7 | 1.4 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.7 | 5.5 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.7 | 3.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.7 | 4.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.7 | 2.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.7 | 3.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.7 | 1.4 | GO:0031296 | B cell costimulation(GO:0031296) |
0.7 | 2.0 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.7 | 5.5 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.7 | 4.8 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.7 | 1.4 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.7 | 1.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.7 | 1.4 | GO:0006868 | glutamine transport(GO:0006868) |
0.7 | 3.4 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.7 | 1.3 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.7 | 4.0 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.7 | 0.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.7 | 2.7 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.7 | 1.3 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.7 | 8.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.7 | 1.3 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.7 | 1.3 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.7 | 3.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.7 | 2.0 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.7 | 0.7 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.7 | 0.7 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.7 | 1.3 | GO:0070836 | caveola assembly(GO:0070836) |
0.7 | 2.6 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.7 | 2.6 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.7 | 8.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.6 | 0.6 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.6 | 4.5 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.6 | 1.9 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.6 | 1.9 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.6 | 0.6 | GO:0051593 | response to folic acid(GO:0051593) |
0.6 | 1.3 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.6 | 1.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.6 | 3.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.6 | 1.9 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.6 | 0.6 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.6 | 1.3 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.6 | 0.6 | GO:0050955 | thermoception(GO:0050955) |
0.6 | 0.6 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.6 | 5.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.6 | 1.3 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.6 | 1.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.6 | 3.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.6 | 6.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.6 | 19.8 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.6 | 1.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.6 | 1.8 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.6 | 1.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.6 | 2.5 | GO:0072512 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.6 | 0.6 | GO:0015669 | gas transport(GO:0015669) |
0.6 | 3.1 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.6 | 2.4 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.6 | 1.2 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.6 | 1.2 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.6 | 1.8 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.6 | 7.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.6 | 0.6 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.6 | 1.2 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.6 | 1.2 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.6 | 1.2 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.6 | 0.6 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.6 | 7.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.6 | 1.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.6 | 4.8 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.6 | 0.6 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.6 | 0.6 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.6 | 2.4 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.6 | 4.1 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.6 | 0.6 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.6 | 3.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.6 | 0.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.6 | 1.8 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.6 | 1.8 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.6 | 1.8 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.6 | 3.5 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.6 | 3.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.6 | 1.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.6 | 1.8 | GO:1903798 | regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
0.6 | 1.8 | GO:1903232 | melanosome assembly(GO:1903232) |
0.6 | 1.2 | GO:1902075 | cellular response to salt(GO:1902075) |
0.6 | 4.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.6 | 2.9 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.6 | 1.2 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.6 | 1.7 | GO:0009650 | UV protection(GO:0009650) |
0.6 | 0.6 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.6 | 1.7 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.6 | 3.5 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.6 | 4.0 | GO:0070417 | cellular response to cold(GO:0070417) |
0.6 | 0.6 | GO:0035973 | aggrephagy(GO:0035973) |
0.6 | 1.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.6 | 0.6 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.6 | 4.6 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.6 | 1.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.6 | 1.1 | GO:0021564 | vagus nerve development(GO:0021564) |
0.6 | 5.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.6 | 0.6 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.6 | 1.1 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.6 | 0.6 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.6 | 2.8 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.6 | 1.7 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.6 | 1.1 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.6 | 1.7 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.6 | 2.8 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.6 | 5.5 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.6 | 0.6 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.6 | 2.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.6 | 6.6 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.6 | 2.2 | GO:0002934 | desmosome organization(GO:0002934) |
0.6 | 1.1 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.6 | 2.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.5 | 0.5 | GO:0061010 | gall bladder development(GO:0061010) |
0.5 | 3.3 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.5 | 1.6 | GO:0090559 | regulation of membrane permeability(GO:0090559) |
0.5 | 0.5 | GO:0072361 | negative regulation of cholesterol storage(GO:0010887) regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.5 | 1.6 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.5 | 1.1 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.5 | 10.4 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.5 | 3.3 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.5 | 10.9 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.5 | 1.6 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.5 | 1.1 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.5 | 4.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.5 | 7.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.5 | 5.4 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.5 | 1.6 | GO:0018158 | protein oxidation(GO:0018158) |
0.5 | 1.6 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.5 | 0.5 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.5 | 1.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.5 | 3.8 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.5 | 1.6 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.5 | 2.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.5 | 1.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.5 | 1.1 | GO:0043489 | RNA stabilization(GO:0043489) |
0.5 | 1.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.5 | 2.7 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.5 | 1.6 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.5 | 0.5 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.5 | 3.7 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.5 | 0.5 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.5 | 1.1 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.5 | 2.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.5 | 1.1 | GO:1904748 | regulation of apoptotic process involved in development(GO:1904748) |
0.5 | 5.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.5 | 1.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.5 | 2.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.5 | 3.7 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.5 | 1.0 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.5 | 1.0 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.5 | 2.6 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.5 | 0.5 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.5 | 3.6 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.5 | 2.1 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.5 | 4.1 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.5 | 3.6 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.5 | 7.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.5 | 0.5 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.5 | 1.5 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.5 | 2.5 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.5 | 0.5 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.5 | 2.0 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.5 | 1.0 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.5 | 2.0 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.5 | 2.0 | GO:0015809 | arginine transport(GO:0015809) |
0.5 | 1.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.5 | 4.0 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.5 | 0.5 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.5 | 2.5 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
0.5 | 1.0 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.5 | 1.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.5 | 1.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.5 | 2.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.5 | 2.0 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.5 | 4.0 | GO:0043248 | proteasome assembly(GO:0043248) |
0.5 | 13.5 | GO:0006953 | acute-phase response(GO:0006953) |
0.5 | 3.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.5 | 11.4 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.5 | 2.0 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.5 | 5.9 | GO:0043486 | histone exchange(GO:0043486) |
0.5 | 2.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.5 | 3.0 | GO:0030002 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
0.5 | 1.5 | GO:0001555 | oocyte growth(GO:0001555) |
0.5 | 1.5 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.5 | 1.0 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.5 | 2.4 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.5 | 1.5 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.5 | 1.5 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.5 | 1.5 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.5 | 0.5 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.5 | 1.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.5 | 1.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.5 | 4.9 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.5 | 5.8 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.5 | 0.5 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.5 | 1.0 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.5 | 1.0 | GO:0030576 | Cajal body organization(GO:0030576) |
0.5 | 0.5 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.5 | 2.9 | GO:0070166 | enamel mineralization(GO:0070166) |
0.5 | 7.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 2.9 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.5 | 3.9 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.5 | 1.0 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.5 | 0.5 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.5 | 1.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.5 | 3.8 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.5 | 0.5 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.5 | 3.8 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.5 | 4.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.5 | 0.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.5 | 1.4 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.5 | 1.9 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.5 | 5.2 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.5 | 6.1 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.5 | 1.4 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.5 | 0.5 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.5 | 0.5 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.5 | 1.9 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.5 | 3.7 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.5 | 1.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.5 | 1.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.5 | 1.4 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.5 | 0.5 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.5 | 1.9 | GO:0015705 | iodide transport(GO:0015705) |
0.5 | 0.9 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.5 | 5.1 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.5 | 1.9 | GO:0042148 | strand invasion(GO:0042148) |
0.5 | 1.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.5 | 0.9 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.5 | 4.2 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.5 | 1.4 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.5 | 0.5 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.5 | 1.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.5 | 1.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.5 | 1.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.5 | 3.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.5 | 0.9 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.5 | 1.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.5 | 2.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.5 | 1.8 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.5 | 1.8 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) |
0.5 | 1.4 | GO:0010226 | response to lithium ion(GO:0010226) |
0.5 | 1.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.5 | 1.4 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.5 | 2.7 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.5 | 1.4 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.5 | 2.3 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.5 | 0.5 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.4 | 2.7 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.4 | 1.8 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.4 | 1.3 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.4 | 1.8 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.4 | 0.9 | GO:0016264 | gap junction assembly(GO:0016264) |
0.4 | 2.2 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.4 | 6.7 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.4 | 0.4 | GO:0033058 | directional locomotion(GO:0033058) |
0.4 | 0.9 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.4 | 0.9 | GO:0043308 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.4 | 0.4 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.4 | 0.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.4 | 0.4 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.4 | 1.3 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.4 | 0.9 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.4 | 5.3 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.4 | 2.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.4 | 0.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.4 | 1.3 | GO:0014029 | neural crest formation(GO:0014029) |
0.4 | 2.2 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.4 | 0.4 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.4 | 2.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.4 | 0.9 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.4 | 2.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.4 | 2.1 | GO:0070305 | response to cGMP(GO:0070305) |
0.4 | 5.1 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.4 | 0.4 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.4 | 15.0 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.4 | 2.1 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.4 | 2.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.4 | 0.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.4 | 2.6 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.4 | 3.0 | GO:0009299 | mRNA transcription(GO:0009299) |
0.4 | 0.4 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.4 | 0.8 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.4 | 1.3 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.4 | 5.9 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.4 | 0.8 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.4 | 0.8 | GO:0036394 | amylase secretion(GO:0036394) |
0.4 | 5.0 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.4 | 0.4 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.4 | 1.3 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.4 | 2.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.4 | 0.4 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.4 | 0.8 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.4 | 0.4 | GO:0042117 | monocyte activation(GO:0042117) |
0.4 | 0.4 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.4 | 5.8 | GO:0002347 | response to tumor cell(GO:0002347) |
0.4 | 0.8 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) pericentric heterochromatin assembly(GO:0031508) |
0.4 | 6.2 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.4 | 2.9 | GO:0043084 | penile erection(GO:0043084) |
0.4 | 0.8 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.4 | 0.8 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.4 | 1.2 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.4 | 0.4 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.4 | 0.4 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 0.8 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.4 | 0.8 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.4 | 2.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.4 | 0.8 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.4 | 0.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.4 | 0.4 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.4 | 0.8 | GO:0060926 | cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
0.4 | 0.8 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 2.8 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.4 | 2.4 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.4 | 4.4 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 0.4 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
0.4 | 6.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.4 | 0.8 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.4 | 3.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.4 | 0.8 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.4 | 0.4 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.4 | 0.8 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.4 | 2.0 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.4 | 1.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.4 | 0.4 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.4 | 0.4 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.4 | 1.2 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.4 | 2.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.4 | 1.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.4 | 0.4 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.4 | 1.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.4 | 2.8 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.4 | 0.4 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.4 | 2.4 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.4 | 2.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.4 | 11.0 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.4 | 0.8 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.4 | 0.4 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.4 | 2.0 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.4 | 0.4 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.4 | 0.4 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.4 | 5.1 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.4 | 0.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.4 | 1.2 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.4 | 0.8 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.4 | 1.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.4 | 0.4 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.4 | 0.4 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.4 | 0.4 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.4 | 1.2 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.4 | 0.4 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.4 | 0.4 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.4 | 0.8 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.4 | 0.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.4 | 3.5 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.4 | 2.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.4 | 1.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.4 | 1.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.4 | 6.1 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.4 | 0.8 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.4 | 0.8 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.4 | 2.7 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.4 | 0.8 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.4 | 1.5 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.4 | 1.1 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.4 | 1.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.4 | 1.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 0.8 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.4 | 1.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.4 | 18.0 | GO:0051225 | spindle assembly(GO:0051225) |
0.4 | 1.1 | GO:0046463 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.4 | 0.7 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.4 | 1.9 | GO:0030575 | nuclear body organization(GO:0030575) |
0.4 | 1.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.4 | 0.4 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.4 | 0.7 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.4 | 1.1 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.4 | 10.0 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.4 | 1.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.4 | 1.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.4 | 1.5 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.4 | 5.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.4 | 0.7 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.4 | 1.5 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.4 | 1.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.4 | 1.5 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.4 | 4.0 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.4 | 0.7 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.4 | 4.4 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.4 | 0.7 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.4 | 2.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.4 | 0.4 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.4 | 2.2 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.4 | 0.4 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.4 | 0.7 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.4 | 0.4 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.4 | 1.1 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.4 | 0.4 | GO:0010042 | response to manganese ion(GO:0010042) |
0.4 | 3.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.4 | 2.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.4 | 0.7 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.4 | 1.1 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.4 | 0.7 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.4 | 1.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.4 | 0.4 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.4 | 2.1 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.4 | 0.4 | GO:0034204 | lipid translocation(GO:0034204) |
0.4 | 1.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.4 | 0.4 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.4 | 7.8 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.4 | 2.8 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.4 | 11.9 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.3 | 0.7 | GO:1903726 | negative regulation of phospholipid metabolic process(GO:1903726) |
0.3 | 0.7 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.3 | 1.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.3 | 0.7 | GO:0031126 | peptidyl-glutamine methylation(GO:0018364) snoRNA 3'-end processing(GO:0031126) |
0.3 | 1.0 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.3 | 0.7 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.3 | 0.3 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.3 | 0.3 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.3 | 4.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.3 | 3.5 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.3 | 1.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.3 | 3.8 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.3 | 0.3 | GO:1901725 | positive regulation of deacetylase activity(GO:0090045) regulation of histone deacetylase activity(GO:1901725) positive regulation of histone deacetylase activity(GO:1901727) |
0.3 | 1.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.3 | 0.7 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.3 | 2.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.3 | 0.7 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.3 | 4.1 | GO:0006465 | signal peptide processing(GO:0006465) |
0.3 | 3.4 | GO:0014850 | response to muscle activity(GO:0014850) |
0.3 | 1.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.3 | 2.7 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.3 | 1.0 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.3 | 1.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.3 | 1.7 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.3 | 0.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.3 | 0.7 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.3 | 0.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.3 | 1.0 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.3 | 7.4 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.3 | 2.3 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.3 | 0.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.3 | 2.3 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.3 | 2.3 | GO:0016556 | mRNA modification(GO:0016556) |
0.3 | 0.7 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.3 | 0.7 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.3 | 1.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 2.3 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.3 | 2.0 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.3 | 0.7 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.3 | 2.3 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.3 | 1.3 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.3 | 2.7 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.3 | 0.3 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.3 | 2.0 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.3 | 5.3 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.3 | 0.7 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.3 | 0.7 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.3 | 8.6 | GO:0007032 | endosome organization(GO:0007032) |
0.3 | 3.3 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.3 | 12.5 | GO:0007569 | cell aging(GO:0007569) |
0.3 | 0.7 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.3 | 1.0 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.3 | 1.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.3 | 2.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.3 | 0.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.3 | 2.6 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.3 | 1.0 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.3 | 0.6 | GO:0001757 | somite specification(GO:0001757) |
0.3 | 2.6 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.3 | 1.3 | GO:0014823 | response to activity(GO:0014823) |
0.3 | 12.3 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.3 | 2.9 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.3 | 3.2 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.3 | 1.9 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.3 | 0.6 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.3 | 0.3 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.3 | 2.9 | GO:0000154 | rRNA modification(GO:0000154) |
0.3 | 0.6 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.3 | 5.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 2.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 0.3 | GO:0060426 | lung vasculature development(GO:0060426) |
0.3 | 3.5 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.3 | 0.6 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.3 | 0.3 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.3 | 1.6 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.3 | 1.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 0.9 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.3 | 1.3 | GO:0060068 | vagina development(GO:0060068) |
0.3 | 0.6 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.3 | 4.4 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.3 | 1.6 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.3 | 1.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.3 | 0.6 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.3 | 10.0 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.3 | 10.0 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.3 | 0.3 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.3 | 0.9 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 1.6 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.3 | 0.6 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.3 | 2.8 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.3 | 0.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 1.2 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.3 | 0.3 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.3 | 0.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.3 | 0.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 1.9 | GO:0007097 | nuclear migration(GO:0007097) |
0.3 | 1.6 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.3 | 0.9 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.3 | 7.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.3 | 0.3 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.3 | 0.3 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.3 | 0.9 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.3 | 0.3 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.3 | 0.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.3 | 8.6 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.3 | 2.8 | GO:0048821 | erythrocyte development(GO:0048821) |
0.3 | 3.1 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.3 | 0.6 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.3 | 0.3 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.3 | 3.4 | GO:0060612 | adipose tissue development(GO:0060612) |
0.3 | 0.9 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.3 | 1.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 1.2 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.3 | 1.5 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.3 | 0.9 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.3 | 3.3 | GO:0071514 | genetic imprinting(GO:0071514) |
0.3 | 0.6 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.3 | 0.3 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.3 | 0.6 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.3 | 0.9 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.3 | 6.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 1.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.3 | 1.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.3 | 1.8 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) |
0.3 | 0.3 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.3 | 0.6 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.3 | 0.3 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.3 | 3.3 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.3 | 0.3 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.3 | 0.6 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 0.3 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.3 | 0.3 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.3 | 0.6 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.3 | 1.2 | GO:0032782 | bile acid secretion(GO:0032782) |
0.3 | 0.3 | GO:0044116 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.3 | 0.6 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.3 | 0.6 | GO:0070459 | prolactin secretion(GO:0070459) |
0.3 | 2.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.3 | 0.6 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.3 | 0.6 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.3 | 2.4 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.3 | 0.9 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.3 | 0.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.3 | 4.1 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.3 | 0.6 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.3 | 0.3 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.3 | 1.5 | GO:0007620 | copulation(GO:0007620) |
0.3 | 1.2 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.3 | 0.9 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.3 | 6.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.3 | 13.4 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.3 | 0.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.3 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.3 | 0.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.3 | 0.3 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.3 | 3.7 | GO:0002063 | chondrocyte development(GO:0002063) |
0.3 | 0.3 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.3 | 0.9 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.3 | 1.7 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.3 | 0.6 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.3 | 1.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.3 | 0.3 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.3 | 1.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.3 | 1.4 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.3 | 0.3 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.3 | 0.8 | GO:0019068 | virion assembly(GO:0019068) |
0.3 | 0.3 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.3 | 0.6 | GO:0009838 | abscission(GO:0009838) |
0.3 | 1.4 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.3 | 0.8 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.3 | 1.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.3 | 0.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 0.6 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 0.6 | GO:0002215 | defense response to nematode(GO:0002215) |
0.3 | 1.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.3 | 0.6 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.3 | 0.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.3 | 0.6 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.3 | 4.2 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.3 | 0.8 | GO:0030033 | microvillus assembly(GO:0030033) |
0.3 | 0.3 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.3 | 3.9 | GO:0017144 | drug metabolic process(GO:0017144) |
0.3 | 0.6 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.3 | 1.7 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 16.5 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.3 | 0.8 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.3 | 0.8 | GO:0009629 | response to gravity(GO:0009629) |
0.3 | 1.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 2.5 | GO:0098868 | bone growth(GO:0098868) |
0.3 | 0.8 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.3 | 0.3 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.3 | 0.3 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.3 | 3.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.3 | 2.2 | GO:1904353 | regulation of telomere capping(GO:1904353) |
0.3 | 0.5 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.3 | 1.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 0.5 | GO:0098801 | regulation of renal system process(GO:0098801) |
0.3 | 0.3 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.3 | 0.8 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.3 | 1.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.3 | 0.3 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.3 | 0.5 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 0.5 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.3 | 0.3 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.3 | 1.1 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.3 | 0.8 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.3 | 0.5 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.3 | 0.8 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.3 | 1.1 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.3 | 1.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 0.8 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.3 | 5.5 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.3 | 2.9 | GO:0006476 | protein deacetylation(GO:0006476) |
0.3 | 1.0 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.3 | 0.3 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.3 | 0.8 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.3 | 1.0 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 0.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 0.5 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.3 | 1.0 | GO:0051026 | chiasma assembly(GO:0051026) |
0.3 | 1.6 | GO:0009268 | response to pH(GO:0009268) |
0.3 | 0.5 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.3 | 0.8 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.3 | 1.3 | GO:0061008 | hepaticobiliary system development(GO:0061008) |
0.3 | 3.9 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.3 | 0.3 | GO:0032098 | regulation of appetite(GO:0032098) |
0.3 | 1.8 | GO:0015825 | L-serine transport(GO:0015825) |
0.3 | 1.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.3 | 2.6 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.3 | 1.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.3 | 0.3 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.3 | 0.3 | GO:0007567 | parturition(GO:0007567) |
0.3 | 0.5 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.3 | 0.3 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.3 | 0.3 | GO:1901163 | regulation of trophoblast cell migration(GO:1901163) |
0.3 | 0.5 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.3 | 2.0 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.3 | 0.5 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.3 | 0.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 0.3 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.3 | 3.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 0.5 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.3 | 0.3 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.3 | 1.8 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.3 | 1.3 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.3 | 0.5 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) |
0.3 | 1.5 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.2 | 0.7 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.2 | 1.2 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 0.2 | GO:0002337 | B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
0.2 | 0.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.2 | 1.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 0.2 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.2 | 12.7 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.2 | 0.2 | GO:0070254 | mucus secretion(GO:0070254) |
0.2 | 0.2 | GO:0071866 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.2 | 0.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.2 | 0.7 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.2 | 5.7 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.2 | 0.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 0.5 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.2 | 0.5 | GO:0007143 | female meiotic division(GO:0007143) |
0.2 | 0.5 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.2 | 0.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 2.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.2 | 0.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 0.5 | GO:0030730 | positive regulation of sequestering of triglyceride(GO:0010890) sequestering of triglyceride(GO:0030730) |
0.2 | 0.2 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.2 | 2.7 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.7 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 1.7 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.2 | 0.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 1.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.2 | 2.2 | GO:0071467 | cellular response to pH(GO:0071467) |
0.2 | 28.7 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.2 | 0.7 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.2 | 0.2 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.2 | 2.9 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.2 | 6.5 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.2 | 1.7 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.2 | 0.2 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.2 | 0.5 | GO:0001806 | type IV hypersensitivity(GO:0001806) regulation of type IV hypersensitivity(GO:0001807) |
0.2 | 1.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 2.9 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.2 | 0.7 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 0.2 | GO:0021546 | rhombomere development(GO:0021546) |
0.2 | 1.4 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.2 | 1.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 0.2 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.2 | 0.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 1.0 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 0.5 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 1.0 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 0.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 0.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.5 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.2 | 0.7 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.2 | 0.7 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.2 | 0.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 2.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 5.4 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.2 | 5.2 | GO:0043467 | regulation of generation of precursor metabolites and energy(GO:0043467) |
0.2 | 1.4 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.2 | 0.2 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.2 | 0.5 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.2 | 0.2 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.2 | 1.2 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.2 | 0.7 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.2 | 0.7 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.2 | 4.2 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.2 | 1.9 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.2 | 2.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 1.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.2 | 0.5 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 0.7 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.2 | 0.2 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.2 | 3.5 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.2 | 0.5 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 0.7 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 8.1 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.2 | 2.3 | GO:0006096 | glycolytic process(GO:0006096) |
0.2 | 0.5 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.2 | 0.5 | GO:0046909 | intermembrane transport(GO:0046909) |
0.2 | 0.5 | GO:0034505 | tooth mineralization(GO:0034505) |
0.2 | 4.1 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.2 | 0.5 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.2 | 0.9 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 2.3 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.2 | 0.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 0.5 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.2 | 0.9 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.2 | 0.2 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.2 | 2.3 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 0.5 | GO:0010447 | response to acidic pH(GO:0010447) |
0.2 | 5.4 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.2 | 3.8 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 0.9 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 6.6 | GO:0001824 | blastocyst development(GO:0001824) |
0.2 | 0.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.5 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.2 | 1.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.5 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.2 | 0.7 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 2.9 | GO:0070527 | platelet aggregation(GO:0070527) |
0.2 | 0.4 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.2 | 0.4 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.2 | 0.7 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.2 | 1.1 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.2 | 0.9 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.2 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 8.2 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.2 | 16.2 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.2 | 5.1 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.2 | 3.1 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.2 | 1.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.2 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.2 | 0.4 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 0.7 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.2 | 0.4 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.2 | 1.8 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 4.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 3.5 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.2 | 0.2 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
0.2 | 2.6 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.2 | 1.5 | GO:0042730 | fibrinolysis(GO:0042730) |
0.2 | 0.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.2 | 0.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 0.2 | GO:0014831 | intestine smooth muscle contraction(GO:0014827) gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.2 | 0.9 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.2 | 0.9 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.2 | 0.4 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) |
0.2 | 0.9 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.2 | 2.1 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.2 | 5.3 | GO:0003341 | cilium movement(GO:0003341) |
0.2 | 1.7 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.2 | 0.2 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.2 | 0.6 | GO:0007398 | ectoderm development(GO:0007398) |
0.2 | 2.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 3.6 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.2 | 0.9 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 0.4 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.2 | 0.4 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.2 | 0.2 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.2 | 0.2 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.2 | 0.4 | GO:0034311 | diol metabolic process(GO:0034311) |
0.2 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 0.8 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 0.4 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.2 | 0.4 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.2 | 0.8 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 0.6 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 0.2 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.2 | 0.6 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.2 | 0.2 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.2 | 4.4 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.2 | 0.6 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 0.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 4.6 | GO:1901998 | toxin transport(GO:1901998) |
0.2 | 0.4 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 0.4 | GO:0014910 | regulation of smooth muscle cell migration(GO:0014910) |
0.2 | 1.7 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.2 | 0.2 | GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress(GO:0043618) |
0.2 | 0.8 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 0.6 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 9.1 | GO:0050821 | protein stabilization(GO:0050821) |
0.2 | 1.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 1.0 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.2 | 2.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.2 | 0.6 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 1.8 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.2 | 10.6 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.2 | 1.2 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.2 | 0.2 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.2 | 0.4 | GO:0051293 | establishment of spindle localization(GO:0051293) |
0.2 | 0.8 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 2.6 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.2 | 0.6 | GO:0060969 | negative regulation of gene silencing(GO:0060969) |
0.2 | 3.7 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.2 | 0.4 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 1.0 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.2 | 0.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.2 | 1.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 0.4 | GO:0072678 | T cell migration(GO:0072678) |
0.2 | 1.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.2 | 0.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 11.4 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 0.8 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.2 | 1.8 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 0.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 1.4 | GO:0033866 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 0.2 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.2 | 2.0 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.2 | 0.2 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 0.4 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 1.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 1.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 2.0 | GO:0050892 | intestinal absorption(GO:0050892) |
0.2 | 0.4 | GO:0042161 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.2 | 0.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 0.4 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.2 | 0.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.6 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.2 | 1.6 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 2.2 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.2 | 0.2 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.2 | 5.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 0.4 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
0.2 | 1.2 | GO:0001890 | placenta development(GO:0001890) |
0.2 | 0.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.2 | 0.8 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.6 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 0.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 0.2 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.2 | 1.5 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.2 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 0.4 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.2 | 0.2 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.2 | 0.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 | 0.4 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.2 | 9.0 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.2 | 0.6 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 0.6 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.2 | 3.8 | GO:0007566 | embryo implantation(GO:0007566) |
0.2 | 0.9 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.2 | 1.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.2 | 0.2 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.2 | 2.4 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.2 | 0.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.2 | 0.2 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.2 | 0.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.4 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 0.2 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.2 | 0.9 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.2 | 0.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.2 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.2 | 0.2 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.2 | 0.6 | GO:1904375 | regulation of protein localization to plasma membrane(GO:1903076) regulation of protein localization to cell periphery(GO:1904375) |
0.2 | 1.9 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.2 | 3.0 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.2 | 0.2 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.2 | 5.0 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.2 | 0.6 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.2 | 0.2 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.2 | 0.7 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 0.2 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.2 | 0.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.5 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.2 | 0.4 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.2 | 0.7 | GO:0043297 | apical junction assembly(GO:0043297) |
0.2 | 1.3 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.2 | 0.2 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.2 | 2.9 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.2 | 0.5 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.2 | 0.2 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.2 | 0.7 | GO:0009147 | pyrimidine nucleoside triphosphate metabolic process(GO:0009147) pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) pyrimidine ribonucleotide metabolic process(GO:0009218) pyrimidine ribonucleoside metabolic process(GO:0046131) |
0.2 | 0.4 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 0.2 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) dopamine catabolic process(GO:0042420) catecholamine catabolic process(GO:0042424) |
0.2 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 0.2 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.2 | 12.5 | GO:0051321 | meiotic cell cycle(GO:0051321) |
0.2 | 0.2 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 0.2 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.2 | 0.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.2 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.5 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.2 | 1.8 | GO:0015858 | nucleoside transport(GO:0015858) |
0.2 | 0.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 0.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 3.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 0.2 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.2 | 1.6 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.2 | 0.5 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.2 | 1.4 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 0.3 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.2 | 1.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 1.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.2 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.2 | 0.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 0.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 0.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.9 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 0.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 1.0 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.2 | 0.2 | GO:0072012 | glomerulus vasculature development(GO:0072012) |
0.2 | 0.2 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.2 | 0.3 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.2 | 0.2 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.2 | 1.2 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.2 | 0.9 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.2 | 2.6 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.2 | 0.5 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.2 | 0.2 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 0.7 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.2 | 0.2 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.2 | 0.3 | GO:0006650 | glycerophospholipid metabolic process(GO:0006650) |
0.2 | 0.8 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 0.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.2 | 0.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 0.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 0.7 | GO:0042048 | olfactory behavior(GO:0042048) |
0.2 | 0.3 | GO:0030220 | platelet formation(GO:0030220) |
0.2 | 0.7 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 1.2 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
0.2 | 0.5 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.2 | 0.7 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.2 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.2 | 0.2 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.2 | 0.3 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
0.2 | 0.3 | GO:1901660 | calcium ion export(GO:1901660) |
0.2 | 3.5 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.2 | 0.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 6.9 | GO:0006690 | icosanoid metabolic process(GO:0006690) fatty acid derivative metabolic process(GO:1901568) |
0.2 | 1.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.2 | 5.6 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.2 | 0.3 | GO:0070542 | response to fatty acid(GO:0070542) |
0.2 | 0.2 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
0.2 | 0.2 | GO:0019076 | viral release from host cell(GO:0019076) |
0.2 | 0.2 | GO:0035459 | cargo loading into vesicle(GO:0035459) cargo loading into COPII-coated vesicle(GO:0090110) |
0.2 | 3.4 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.2 | 0.3 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.5 | GO:0061035 | regulation of cartilage development(GO:0061035) |
0.2 | 0.3 | GO:0035878 | nail development(GO:0035878) |
0.2 | 0.8 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.2 | 0.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 0.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.2 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.2 | 0.2 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 1.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 3.0 | GO:0015931 | nucleobase-containing compound transport(GO:0015931) |
0.2 | 1.0 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.2 | 0.2 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.5 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.2 | 0.2 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.2 | 0.3 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.2 | 0.2 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.2 | 1.1 | GO:0002076 | osteoblast development(GO:0002076) |
0.2 | 0.3 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.2 | 0.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 0.8 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.2 | 0.2 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.2 | 0.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.3 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.2 | 0.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 0.3 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.3 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.2 | 0.2 | GO:1903428 | positive regulation of reactive oxygen species biosynthetic process(GO:1903428) |
0.2 | 0.5 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.2 | 1.6 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 0.3 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.2 | 0.2 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.2 | 0.5 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 1.2 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.2 | 0.8 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.2 | 0.3 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.2 | 0.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.2 | 1.8 | GO:0045639 | positive regulation of myeloid cell differentiation(GO:0045639) |
0.2 | 2.6 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.2 | 2.7 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.2 | 0.2 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.2 | 0.9 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.2 | 0.2 | GO:0003170 | heart valve development(GO:0003170) |
0.2 | 0.6 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 1.2 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.2 | 0.2 | GO:0071451 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.2 | 0.3 | GO:0034756 | iron ion transmembrane transport(GO:0034755) regulation of iron ion transport(GO:0034756) |
0.2 | 0.3 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.2 | 0.9 | GO:0006342 | chromatin silencing(GO:0006342) |
0.1 | 0.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.1 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.1 | GO:0015865 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.1 | 5.2 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.1 | 6.0 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.3 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.1 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 11.1 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.1 | 0.1 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.1 | 0.4 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 1.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.6 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.1 | GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) |
0.1 | 0.3 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 1.5 | GO:0052696 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.1 | 0.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.7 | GO:0006323 | DNA packaging(GO:0006323) |
0.1 | 7.1 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
0.1 | 0.7 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.3 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.1 | 0.3 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.1 | 0.7 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.1 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.1 | 2.6 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.1 | 4.9 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.3 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.1 | 2.3 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.1 | 0.3 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.6 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 1.7 | GO:0019915 | lipid storage(GO:0019915) |
0.1 | 0.4 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 4.5 | GO:0006665 | sphingolipid metabolic process(GO:0006665) |
0.1 | 2.0 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.1 | 0.3 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.6 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 1.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.1 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 0.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 2.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.1 | GO:0061448 | connective tissue development(GO:0061448) |
0.1 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.4 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 1.0 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.1 | 0.3 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.3 | GO:0006091 | generation of precursor metabolites and energy(GO:0006091) |
0.1 | 0.4 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.4 | GO:0001936 | regulation of endothelial cell proliferation(GO:0001936) |
0.1 | 0.3 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.1 | 7.4 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.3 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.1 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 1.5 | GO:0010498 | proteasomal protein catabolic process(GO:0010498) |
0.1 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.1 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.9 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 1.3 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.4 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.1 | 0.4 | GO:0048659 | smooth muscle cell proliferation(GO:0048659) |
0.1 | 0.9 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.5 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.1 | 0.5 | GO:0061515 | myeloid cell development(GO:0061515) |
0.1 | 0.4 | GO:0070076 | histone lysine demethylation(GO:0070076) |
0.1 | 0.1 | GO:1903036 | positive regulation of response to wounding(GO:1903036) |
0.1 | 1.1 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.1 | 0.5 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.1 | 0.1 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.1 | 4.9 | GO:0045088 | regulation of innate immune response(GO:0045088) |
0.1 | 0.1 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.1 | 0.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 2.1 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.3 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.1 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.1 | 0.1 | GO:0046006 | regulation of activated T cell proliferation(GO:0046006) |
0.1 | 0.8 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 1.6 | GO:0045216 | cell-cell junction organization(GO:0045216) |
0.1 | 0.3 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 6.5 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 2.5 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 3.7 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.1 | 0.5 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.4 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.1 | 0.3 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.1 | 12.5 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 1.9 | GO:0019439 | aromatic compound catabolic process(GO:0019439) |
0.1 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 1.0 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 0.1 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.1 | 0.8 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.1 | 0.4 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.1 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 0.3 | GO:0045778 | positive regulation of ossification(GO:0045778) |
0.1 | 0.5 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.1 | GO:0046209 | nitric oxide metabolic process(GO:0046209) |
0.1 | 2.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 1.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.2 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.2 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.1 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.4 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 1.5 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 1.1 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.5 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.1 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.1 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.5 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.1 | 1.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.1 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 0.2 | GO:0071357 | cellular response to type I interferon(GO:0071357) |
0.1 | 0.1 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.1 | 1.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.4 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.1 | 1.1 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.3 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.5 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.1 | 0.3 | GO:0042711 | maternal behavior(GO:0042711) |
0.1 | 0.2 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.1 | 0.2 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.5 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.1 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.1 | 0.2 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 2.0 | GO:1903844 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
0.1 | 0.1 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.1 | 0.1 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.1 | 1.1 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.1 | GO:1902309 | peptidyl-serine dephosphorylation(GO:0070262) negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.1 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.1 | 4.6 | GO:0016568 | chromatin modification(GO:0016568) |
0.1 | 1.2 | GO:0098930 | axonal transport(GO:0098930) |
0.1 | 0.4 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.1 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
0.1 | 0.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.1 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.1 | GO:0003163 | sinoatrial node development(GO:0003163) |
0.1 | 0.9 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 1.9 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 3.6 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 1.0 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.1 | 0.2 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 0.1 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 0.1 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 1.6 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) |
0.1 | 0.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.1 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.1 | 0.3 | GO:0031280 | negative regulation of cyclase activity(GO:0031280) |
0.1 | 0.5 | GO:0007565 | female pregnancy(GO:0007565) |
0.1 | 0.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 0.4 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.1 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.1 | 0.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.5 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.1 | 0.1 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) |
0.1 | 0.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.1 | 4.0 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.1 | 1.6 | GO:0048477 | oogenesis(GO:0048477) |
0.1 | 0.8 | GO:0050764 | regulation of phagocytosis(GO:0050764) |
0.1 | 0.3 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 3.2 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 1.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.6 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 3.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.1 | GO:0033033 | neutrophil apoptotic process(GO:0001781) negative regulation of neutrophil apoptotic process(GO:0033030) negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.1 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.1 | 0.6 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 4.2 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.4 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 1.8 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.2 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.1 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
0.1 | 0.1 | GO:0071549 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 0.1 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 9.8 | GO:0007283 | spermatogenesis(GO:0007283) |
0.1 | 1.8 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 0.1 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.1 | 0.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.1 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 0.2 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.1 | 2.3 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.1 | 4.3 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.1 | 0.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.4 | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043280) |
0.1 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.1 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.1 | 0.3 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.1 | 0.1 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.1 | 0.1 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.1 | 0.1 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.1 | 0.2 | GO:0006638 | neutral lipid metabolic process(GO:0006638) |
0.1 | 0.2 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.1 | 0.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 4.6 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 0.1 | GO:0010224 | response to UV-B(GO:0010224) |
0.1 | 0.2 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 0.5 | GO:0071897 | DNA biosynthetic process(GO:0071897) |
0.1 | 0.9 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.5 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.1 | 0.2 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.8 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.1 | 0.3 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.3 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.4 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.1 | 0.5 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.5 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.1 | GO:0032530 | regulation of microvillus organization(GO:0032530) |
0.1 | 1.0 | GO:0007588 | excretion(GO:0007588) |
0.1 | 1.0 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
0.1 | 0.2 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 0.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.1 | 0.2 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 1.3 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 4.6 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.1 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 7.2 | GO:0001501 | skeletal system development(GO:0001501) |
0.1 | 0.5 | GO:0009411 | response to UV(GO:0009411) |
0.1 | 0.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.1 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.1 | 0.1 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.7 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.1 | 0.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.2 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.1 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.1 | 0.5 | GO:0009896 | positive regulation of catabolic process(GO:0009896) |
0.1 | 0.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.2 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 0.2 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.1 | 0.1 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.1 | 0.4 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.2 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.9 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.1 | 0.1 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.1 | 0.1 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.7 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.1 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.1 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.1 | 2.1 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 0.1 | GO:0071559 | response to transforming growth factor beta(GO:0071559) |
0.1 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 3.3 | GO:0006869 | lipid transport(GO:0006869) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.1 | GO:0006643 | membrane lipid metabolic process(GO:0006643) |
0.1 | 0.1 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 0.5 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.3 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) |
0.1 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.1 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 5.3 | GO:0032259 | methylation(GO:0032259) |
0.1 | 0.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.3 | GO:0006575 | cellular modified amino acid metabolic process(GO:0006575) |
0.1 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 2.4 | GO:0043086 | negative regulation of catalytic activity(GO:0043086) |
0.1 | 0.2 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.1 | 0.1 | GO:0042755 | eating behavior(GO:0042755) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.1 | GO:0046632 | alpha-beta T cell differentiation(GO:0046632) |
0.1 | 4.2 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 0.1 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.2 | GO:0046782 | negative regulation of viral transcription(GO:0032897) regulation of viral transcription(GO:0046782) |
0.1 | 0.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 0.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 5.3 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.1 | 0.2 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.1 | 0.2 | GO:0003014 | renal system process(GO:0003014) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0097484 | dendrite extension(GO:0097484) |
0.1 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.1 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.2 | GO:0001570 | vasculogenesis(GO:0001570) |
0.1 | 0.2 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 0.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 1.8 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.1 | 0.1 | GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway(GO:2001237) |
0.1 | 0.2 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.1 | 0.4 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.2 | GO:0045766 | positive regulation of angiogenesis(GO:0045766) |
0.1 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.5 | GO:0098926 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.1 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.1 | 0.1 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 0.1 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.1 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 0.3 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.1 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 3.1 | GO:0009617 | response to bacterium(GO:0009617) |
0.1 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.1 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 1.4 | GO:0042060 | wound healing(GO:0042060) |
0.1 | 0.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 0.9 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.4 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 2.0 | GO:0043062 | extracellular structure organization(GO:0043062) |
0.1 | 0.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.5 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.1 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.1 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.0 | 0.0 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.0 | 5.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.0 | 0.4 | GO:0030819 | positive regulation of cAMP metabolic process(GO:0030816) positive regulation of cAMP biosynthetic process(GO:0030819) |
0.0 | 0.0 | GO:0006473 | protein acetylation(GO:0006473) |
0.0 | 0.0 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.3 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.2 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) |
0.0 | 0.0 | GO:0033273 | response to vitamin(GO:0033273) |
0.0 | 0.0 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.2 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.0 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 1.8 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.0 | 0.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.0 | 0.0 | GO:0044843 | cell cycle G1/S phase transition(GO:0044843) |
0.0 | 0.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.3 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.1 | GO:0043543 | protein acylation(GO:0043543) |
0.0 | 0.3 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.0 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.1 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.7 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.0 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.0 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.0 | 0.2 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.0 | 0.0 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.0 | 0.9 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.0 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.0 | GO:0021586 | pons maturation(GO:0021586) |
0.0 | 0.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.1 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.0 | 0.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.1 | GO:0046427 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.0 | 0.1 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.0 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.0 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.0 | 0.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.0 | 0.0 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.0 | 0.1 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.0 | 0.0 | GO:0042107 | cytokine metabolic process(GO:0042107) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 7.0 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.0 | 0.0 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
0.0 | 0.0 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.0 | 32.4 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.0 | GO:0007418 | ventral midline development(GO:0007418) |
0.0 | 0.0 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.1 | GO:0051875 | pigment granule localization(GO:0051875) |
0.0 | 0.1 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.0 | 0.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.2 | GO:0045580 | regulation of T cell differentiation(GO:0045580) |
0.0 | 0.0 | GO:0042476 | odontogenesis(GO:0042476) |
0.0 | 0.0 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.2 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.0 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.0 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.0 | GO:0051341 | regulation of oxidoreductase activity(GO:0051341) |
0.0 | 0.0 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.0 | 0.0 | GO:0046631 | alpha-beta T cell activation(GO:0046631) |
0.0 | 0.3 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.1 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 0.0 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.0 | 0.3 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.0 | 0.0 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.0 | 0.0 | GO:0032200 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.0 | 0.0 | GO:0006833 | water transport(GO:0006833) |
0.0 | 0.0 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.0 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.0 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0070231 | T cell apoptotic process(GO:0070231) |
0.0 | 0.0 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 0.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.0 | GO:0032528 | microvillus organization(GO:0032528) |
0.0 | 0.0 | GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002824) |
0.0 | 0.0 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.0 | 0.0 | GO:0055008 | cardiac muscle tissue morphogenesis(GO:0055008) |
0.0 | 0.0 | GO:0036514 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.0 | 0.0 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.0 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.0 | 0.3 | GO:0043331 | response to dsRNA(GO:0043331) |
0.0 | 0.0 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.0 | 0.0 | GO:0002467 | germinal center formation(GO:0002467) |
0.0 | 0.4 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 14.2 | GO:0097413 | Lewy body(GO:0097413) |
3.5 | 10.6 | GO:0097149 | centralspindlin complex(GO:0097149) |
3.4 | 16.9 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
3.1 | 9.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
2.9 | 8.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
2.3 | 34.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
2.3 | 6.8 | GO:0097513 | myosin II filament(GO:0097513) |
2.2 | 6.7 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.8 | 9.2 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
1.8 | 1.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.8 | 7.0 | GO:0005726 | perichromatin fibrils(GO:0005726) |
1.8 | 7.0 | GO:0071953 | elastic fiber(GO:0071953) |
1.7 | 6.7 | GO:0045298 | tubulin complex(GO:0045298) |
1.6 | 4.9 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.6 | 11.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.6 | 6.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.5 | 4.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.5 | 8.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.4 | 4.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.3 | 5.4 | GO:0097452 | GAIT complex(GO:0097452) |
1.3 | 20.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.3 | 3.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.2 | 1.2 | GO:0000125 | PCAF complex(GO:0000125) |
1.2 | 8.4 | GO:0090543 | Flemming body(GO:0090543) |
1.2 | 16.7 | GO:0000974 | Prp19 complex(GO:0000974) |
1.2 | 5.9 | GO:0005638 | lamin filament(GO:0005638) |
1.2 | 5.9 | GO:0045180 | basal cortex(GO:0045180) |
1.2 | 3.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.1 | 12.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.1 | 4.4 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.1 | 2.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
1.1 | 1.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.1 | 4.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.1 | 11.7 | GO:0031143 | pseudopodium(GO:0031143) |
1.1 | 1.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
1.1 | 3.2 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.0 | 8.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.0 | 4.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.0 | 4.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.9 | 2.8 | GO:0070552 | BRISC complex(GO:0070552) |
0.9 | 5.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.9 | 3.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.9 | 17.4 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.9 | 4.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.9 | 2.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.9 | 3.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.9 | 0.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.9 | 2.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.9 | 2.6 | GO:0097443 | sorting endosome(GO:0097443) |
0.9 | 5.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.8 | 5.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.8 | 4.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.8 | 5.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.8 | 0.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.8 | 0.8 | GO:0071203 | WASH complex(GO:0071203) |
0.8 | 5.7 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.8 | 10.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.8 | 3.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.8 | 6.2 | GO:0005861 | troponin complex(GO:0005861) |
0.8 | 2.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.8 | 3.8 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.7 | 1.5 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.7 | 8.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.7 | 1.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.7 | 6.6 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.7 | 2.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.7 | 3.6 | GO:0008091 | spectrin(GO:0008091) |
0.7 | 5.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.7 | 5.0 | GO:0005688 | U6 snRNP(GO:0005688) |
0.7 | 0.7 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.7 | 3.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.7 | 7.0 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.7 | 9.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.7 | 2.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.7 | 5.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.7 | 5.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.7 | 3.3 | GO:0005827 | polar microtubule(GO:0005827) |
0.7 | 2.6 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.7 | 3.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.7 | 5.2 | GO:0045179 | apical cortex(GO:0045179) |
0.6 | 12.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.6 | 2.6 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.6 | 14.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.6 | 1.9 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.6 | 1.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.6 | 6.2 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.6 | 6.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.6 | 3.7 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.6 | 3.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.6 | 1.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.6 | 11.7 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.6 | 35.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.6 | 1.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.6 | 1.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.6 | 1.2 | GO:0032010 | phagolysosome(GO:0032010) |
0.6 | 0.6 | GO:0034464 | BBSome(GO:0034464) |
0.6 | 3.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.6 | 3.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.6 | 7.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.6 | 1.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.6 | 1.8 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.6 | 7.0 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.6 | 15.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.6 | 4.0 | GO:0043219 | lateral loop(GO:0043219) |
0.6 | 0.6 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.6 | 5.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.6 | 2.9 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.6 | 0.6 | GO:0000812 | Swr1 complex(GO:0000812) |
0.6 | 1.7 | GO:0005745 | m-AAA complex(GO:0005745) |
0.6 | 3.9 | GO:0005694 | chromosome(GO:0005694) |
0.6 | 1.7 | GO:0043679 | axon terminus(GO:0043679) neuron projection terminus(GO:0044306) |
0.6 | 3.9 | GO:0071439 | clathrin complex(GO:0071439) |
0.6 | 3.9 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.6 | 2.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.5 | 2.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.5 | 3.3 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.5 | 19.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.5 | 7.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.5 | 1.6 | GO:0005712 | chiasma(GO:0005712) |
0.5 | 2.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.5 | 4.7 | GO:0002102 | podosome(GO:0002102) |
0.5 | 3.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.5 | 1.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.5 | 1.0 | GO:0016342 | catenin complex(GO:0016342) |
0.5 | 7.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.5 | 4.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.5 | 22.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.5 | 3.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.5 | 6.7 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.5 | 3.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.5 | 5.1 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.5 | 1.5 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.5 | 21.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.5 | 0.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.5 | 2.0 | GO:0005911 | cell-cell junction(GO:0005911) |
0.5 | 5.9 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.5 | 2.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.5 | 3.9 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 2.9 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.5 | 2.9 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.5 | 30.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.5 | 6.7 | GO:0051233 | spindle midzone(GO:0051233) |
0.5 | 1.4 | GO:1990357 | terminal web(GO:1990357) |
0.5 | 5.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.5 | 2.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.5 | 9.4 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.5 | 14.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.5 | 1.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.5 | 7.8 | GO:0030904 | retromer complex(GO:0030904) |
0.5 | 5.9 | GO:0043034 | costamere(GO:0043034) |
0.5 | 5.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.5 | 11.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.4 | 1.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.4 | 10.8 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.4 | 3.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.4 | 1.8 | GO:0035339 | SPOTS complex(GO:0035339) |
0.4 | 1.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.4 | 9.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.4 | 0.9 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.4 | 3.1 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.4 | 11.0 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.4 | 3.1 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.4 | 1.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.4 | 3.5 | GO:0034709 | methylosome(GO:0034709) |
0.4 | 6.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 9.5 | GO:0000786 | nucleosome(GO:0000786) |
0.4 | 5.6 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.4 | 2.6 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.4 | 17.3 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.4 | 3.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.4 | 3.5 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 3.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 2.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 1.3 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.4 | 0.9 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.4 | 3.4 | GO:0031512 | motile primary cilium(GO:0031512) |
0.4 | 1.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.4 | 1.2 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.4 | 1.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.4 | 0.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.4 | 6.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.4 | 3.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.4 | 5.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.4 | 3.2 | GO:0042383 | sarcolemma(GO:0042383) |
0.4 | 4.8 | GO:0005844 | polysome(GO:0005844) |
0.4 | 1.6 | GO:0042583 | chromaffin granule(GO:0042583) |
0.4 | 22.1 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.4 | 18.4 | GO:0005811 | lipid particle(GO:0005811) |
0.4 | 2.0 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.4 | 0.8 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.4 | 9.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.4 | 0.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.4 | 3.9 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.4 | 20.7 | GO:0016363 | nuclear matrix(GO:0016363) |
0.4 | 5.1 | GO:0031430 | M band(GO:0031430) |
0.4 | 0.4 | GO:0016939 | kinesin II complex(GO:0016939) |
0.4 | 1.2 | GO:0000235 | astral microtubule(GO:0000235) |
0.4 | 1.5 | GO:0097470 | ribbon synapse(GO:0097470) |
0.4 | 5.4 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.4 | 0.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.4 | 1.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.4 | 3.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.4 | 0.4 | GO:0090533 | sodium:potassium-exchanging ATPase complex(GO:0005890) cation-transporting ATPase complex(GO:0090533) |
0.4 | 1.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.4 | 0.4 | GO:0042827 | platelet dense granule(GO:0042827) |
0.4 | 1.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.4 | 11.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.4 | 10.9 | GO:0031519 | PcG protein complex(GO:0031519) |
0.4 | 21.0 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.4 | 27.7 | GO:0016607 | nuclear speck(GO:0016607) |
0.4 | 14.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.4 | 1.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.4 | 21.2 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.4 | 5.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.4 | 1.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.4 | 3.2 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.4 | 29.4 | GO:0016604 | nuclear body(GO:0016604) |
0.4 | 1.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.4 | 2.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.4 | 36.3 | GO:0000139 | Golgi membrane(GO:0000139) |
0.4 | 5.6 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.4 | 6.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.4 | 1.4 | GO:0042641 | actomyosin(GO:0042641) |
0.3 | 4.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.3 | 4.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 0.3 | GO:0070069 | cytochrome complex(GO:0070069) |
0.3 | 1.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 1.0 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.3 | 0.7 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.3 | 5.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.3 | 1.4 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.3 | 3.8 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 4.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 0.7 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 1.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.3 | 2.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.3 | 4.4 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.3 | 1.0 | GO:0010369 | chromocenter(GO:0010369) |
0.3 | 2.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 2.0 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 1.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.3 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 1.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.3 | 6.3 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 1.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.3 | 1.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.3 | 5.5 | GO:0090544 | BAF-type complex(GO:0090544) |
0.3 | 0.7 | GO:0005955 | calcineurin complex(GO:0005955) |
0.3 | 0.6 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 9.0 | GO:0043231 | intracellular membrane-bounded organelle(GO:0043231) |
0.3 | 0.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.3 | 10.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.3 | 0.3 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.3 | 0.6 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 1.0 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 2.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.3 | 0.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.3 | 0.9 | GO:0072686 | mitotic spindle(GO:0072686) |
0.3 | 0.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.3 | 0.6 | GO:0000805 | X chromosome(GO:0000805) |
0.3 | 2.8 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 1.2 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 0.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 0.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.3 | 0.9 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 12.6 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.3 | 0.6 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.3 | 66.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.3 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 2.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 0.3 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 1.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.3 | 0.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 0.3 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 2.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 2.1 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 1.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 3.4 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.3 | 7.4 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 2.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 1.4 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 1.7 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.3 | 10.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 0.8 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.3 | 33.1 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.3 | 1.7 | GO:0042599 | lamellar body(GO:0042599) |
0.3 | 2.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 2.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.3 | 7.7 | GO:0016459 | myosin complex(GO:0016459) |
0.3 | 5.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 2.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 1.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.3 | 0.8 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.3 | 26.4 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.3 | 3.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 1.3 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 78.9 | GO:0005813 | centrosome(GO:0005813) |
0.3 | 12.8 | GO:0030018 | Z disc(GO:0030018) |
0.3 | 0.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 0.8 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.3 | 122.0 | GO:0005730 | nucleolus(GO:0005730) |
0.3 | 1.6 | GO:1990752 | microtubule end(GO:1990752) |
0.3 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.3 | 106.1 | GO:0044429 | mitochondrial part(GO:0044429) |
0.3 | 248.1 | GO:0005654 | nucleoplasm(GO:0005654) |
0.3 | 1.6 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.3 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 164.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.3 | 1.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.3 | 0.8 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 0.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 6.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.3 | 1.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 18.2 | GO:0043296 | apical junction complex(GO:0043296) |
0.3 | 0.5 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.3 | 0.8 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.2 | 1.0 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 0.2 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 3.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 2.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 17.5 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.2 | 28.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 9.5 | GO:0010008 | endosome membrane(GO:0010008) |
0.2 | 1.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 200.3 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.2 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 1.1 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 4.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 0.2 | GO:0098858 | actin-based cell projection(GO:0098858) |
0.2 | 0.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 1.9 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 2.5 | GO:0030286 | dynein complex(GO:0030286) |
0.2 | 8.8 | GO:0005770 | late endosome(GO:0005770) |
0.2 | 0.4 | GO:0034708 | methyltransferase complex(GO:0034708) |
0.2 | 1.0 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 0.4 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 0.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 0.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.2 | 0.8 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 0.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 4.1 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 1.8 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 10.3 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.2 | 4.5 | GO:0036064 | ciliary basal body(GO:0036064) |
0.2 | 0.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 0.2 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
0.2 | 0.4 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 0.4 | GO:0072372 | primary cilium(GO:0072372) |
0.2 | 0.2 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 0.4 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 6.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 7.7 | GO:0005938 | cell cortex(GO:0005938) |
0.2 | 5.1 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 16.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 0.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 0.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.2 | 0.5 | GO:1990391 | DNA repair complex(GO:1990391) |
0.2 | 0.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.5 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.2 | 0.4 | GO:0030054 | cell junction(GO:0030054) |
0.2 | 0.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 0.4 | GO:0016528 | sarcoplasm(GO:0016528) |
0.2 | 206.0 | GO:0070062 | extracellular exosome(GO:0070062) |
0.2 | 1.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.2 | 0.5 | GO:0044309 | neuron spine(GO:0044309) |
0.2 | 0.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 0.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 3.5 | GO:0012505 | endomembrane system(GO:0012505) |
0.2 | 1.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.2 | 0.5 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.2 | 1.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 17.4 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 0.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 1.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 0.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 0.2 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 0.3 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 63.6 | GO:0005829 | cytosol(GO:0005829) |
0.2 | 0.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.2 | 0.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 0.5 | GO:0000793 | condensed chromosome(GO:0000793) |
0.2 | 0.6 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.2 | 0.5 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 1.6 | GO:0031252 | cell leading edge(GO:0031252) |
0.1 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.3 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.1 | GO:0031674 | I band(GO:0031674) |
0.1 | 0.8 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 256.1 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 0.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 1.1 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.4 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 3.4 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 0.2 | GO:1904949 | ATPase complex(GO:1904949) |
0.1 | 0.1 | GO:1990234 | transferase complex(GO:1990234) |
0.1 | 0.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.1 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 1.1 | GO:0032991 | macromolecular complex(GO:0032991) |
0.1 | 1.3 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.4 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.1 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 0.4 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 1.6 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 12.6 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 29.6 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 2.2 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 0.1 | GO:0098588 | bounding membrane of organelle(GO:0098588) |
0.1 | 0.6 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.3 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.2 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.1 | 90.6 | GO:0005737 | cytoplasm(GO:0005737) |
0.1 | 8.1 | GO:0098552 | side of membrane(GO:0098552) |
0.1 | 0.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.3 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.0 | 0.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 123.8 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.0 | GO:0043230 | extracellular organelle(GO:0043230) |
0.0 | 0.0 | GO:0031982 | vesicle(GO:0031982) |
0.0 | 9.1 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 5.3 | GO:0016020 | membrane(GO:0016020) |
0.0 | 3.4 | GO:0005622 | intracellular(GO:0005622) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 9.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
3.0 | 15.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
2.9 | 8.7 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
2.5 | 48.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
2.5 | 7.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.5 | 7.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.5 | 17.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
2.4 | 7.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
2.3 | 4.7 | GO:0030172 | troponin C binding(GO:0030172) |
2.3 | 7.0 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
2.3 | 6.9 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
2.3 | 9.2 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
2.3 | 9.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.2 | 6.7 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
2.2 | 8.7 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
2.1 | 6.4 | GO:0048030 | disaccharide binding(GO:0048030) |
2.0 | 7.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
2.0 | 5.9 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
1.9 | 5.7 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
1.9 | 13.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
1.9 | 5.6 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
1.9 | 7.5 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.8 | 5.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.8 | 14.5 | GO:0008430 | selenium binding(GO:0008430) |
1.8 | 10.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
1.8 | 7.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
1.8 | 8.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.8 | 5.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.7 | 7.0 | GO:0009374 | biotin binding(GO:0009374) |
1.7 | 12.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
1.7 | 5.2 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
1.7 | 10.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.7 | 9.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.7 | 5.0 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.6 | 4.9 | GO:0008142 | oxysterol binding(GO:0008142) |
1.6 | 6.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.6 | 12.7 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
1.5 | 4.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.5 | 7.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.5 | 4.6 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.5 | 1.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
1.5 | 4.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.5 | 11.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
1.5 | 5.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.5 | 11.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
1.4 | 5.8 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.4 | 4.3 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.4 | 7.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.4 | 5.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.4 | 4.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.3 | 6.7 | GO:0070061 | fructose binding(GO:0070061) |
1.3 | 8.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
1.3 | 5.2 | GO:0043515 | kinetochore binding(GO:0043515) |
1.3 | 11.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.3 | 2.6 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
1.3 | 3.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.3 | 3.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.3 | 5.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.2 | 15.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.2 | 5.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.2 | 4.9 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.2 | 1.2 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
1.2 | 3.6 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.2 | 4.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.2 | 7.1 | GO:0043814 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
1.1 | 3.4 | GO:0050692 | DBD domain binding(GO:0050692) |
1.1 | 15.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.1 | 17.0 | GO:0030275 | LRR domain binding(GO:0030275) |
1.1 | 25.6 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
1.1 | 3.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.1 | 3.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.1 | 5.4 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.1 | 13.0 | GO:0017166 | vinculin binding(GO:0017166) |
1.1 | 5.3 | GO:0016530 | metallochaperone activity(GO:0016530) |
1.1 | 22.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
1.0 | 3.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.0 | 6.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.0 | 3.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
1.0 | 3.0 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
1.0 | 3.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.0 | 2.0 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
1.0 | 5.9 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.0 | 2.9 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
1.0 | 10.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
1.0 | 3.8 | GO:0042731 | PH domain binding(GO:0042731) |
1.0 | 2.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.0 | 2.9 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.9 | 7.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.9 | 2.8 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.9 | 0.9 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.9 | 2.7 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.9 | 3.6 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.9 | 4.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.9 | 3.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.9 | 2.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.9 | 8.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.9 | 6.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.9 | 2.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.9 | 7.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.9 | 4.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.9 | 1.7 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.8 | 5.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.8 | 10.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.8 | 7.5 | GO:0043762 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.8 | 27.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.8 | 5.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.8 | 19.0 | GO:0030515 | snoRNA binding(GO:0030515) |
0.8 | 2.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.8 | 3.3 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.8 | 2.5 | GO:0001032 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.8 | 4.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.8 | 4.9 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.8 | 6.5 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.8 | 6.5 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.8 | 3.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.8 | 1.6 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.8 | 3.2 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.8 | 4.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.8 | 4.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.8 | 4.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.8 | 2.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.8 | 3.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.8 | 3.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.8 | 4.7 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.8 | 2.3 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.8 | 7.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.8 | 11.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.8 | 3.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.8 | 0.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.8 | 6.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.8 | 1.5 | GO:0070538 | oleic acid binding(GO:0070538) |
0.8 | 2.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.7 | 0.7 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.7 | 3.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.7 | 2.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.7 | 2.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.7 | 2.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.7 | 7.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.7 | 2.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.7 | 6.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.7 | 9.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.7 | 2.9 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.7 | 22.2 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.7 | 2.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.7 | 1.4 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.7 | 2.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.7 | 3.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.7 | 2.1 | GO:0071253 | connexin binding(GO:0071253) |
0.7 | 4.2 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.7 | 0.7 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.7 | 2.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.7 | 2.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.7 | 2.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.7 | 7.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.7 | 2.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.7 | 2.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.7 | 3.4 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.7 | 0.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.7 | 3.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.7 | 2.7 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.7 | 3.3 | GO:0016151 | nickel cation binding(GO:0016151) |
0.7 | 9.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.7 | 5.9 | GO:0070513 | death domain binding(GO:0070513) |
0.7 | 2.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.7 | 1.3 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) amidine-lyase activity(GO:0016842) |
0.7 | 5.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.6 | 4.5 | GO:0018633 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.6 | 2.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.6 | 2.6 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.6 | 7.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.6 | 1.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.6 | 3.8 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.6 | 1.3 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.6 | 3.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.6 | 2.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.6 | 5.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.6 | 4.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.6 | 1.8 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.6 | 2.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.6 | 1.8 | GO:0004096 | catalase activity(GO:0004096) |
0.6 | 2.5 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.6 | 1.8 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.6 | 3.7 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.6 | 2.4 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.6 | 3.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.6 | 0.6 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.6 | 3.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.6 | 5.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.6 | 1.8 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.6 | 1.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.6 | 0.6 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.6 | 1.7 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.6 | 2.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.6 | 1.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.6 | 5.2 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.6 | 16.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.6 | 2.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.6 | 9.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.6 | 8.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.6 | 3.4 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.6 | 6.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.6 | 2.9 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.6 | 9.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.6 | 2.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.6 | 1.7 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.6 | 7.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.6 | 2.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.6 | 3.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.6 | 1.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.6 | 1.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.6 | 1.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.6 | 2.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.5 | 2.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.5 | 1.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.5 | 1.6 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.5 | 1.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.5 | 14.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.5 | 7.0 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.5 | 3.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.5 | 0.5 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.5 | 8.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.5 | 3.7 | GO:0000150 | recombinase activity(GO:0000150) |
0.5 | 3.7 | GO:0035173 | histone kinase activity(GO:0035173) |
0.5 | 3.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.5 | 6.8 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.5 | 7.3 | GO:0005521 | lamin binding(GO:0005521) |
0.5 | 1.6 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.5 | 4.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.5 | 0.5 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.5 | 3.6 | GO:0005123 | death receptor binding(GO:0005123) |
0.5 | 9.9 | GO:0030506 | ankyrin binding(GO:0030506) |
0.5 | 0.5 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.5 | 1.6 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.5 | 4.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.5 | 1.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.5 | 3.1 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.5 | 2.6 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.5 | 7.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.5 | 1.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.5 | 2.6 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.5 | 5.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.5 | 1.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.5 | 1.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.5 | 7.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.5 | 0.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.5 | 6.0 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.5 | 6.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.5 | 1.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.5 | 4.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.5 | 6.0 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.5 | 1.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.5 | 1.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.5 | 0.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.5 | 5.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.5 | 6.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 1.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.5 | 4.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.5 | 6.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.5 | 7.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.5 | 1.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.5 | 3.9 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.5 | 1.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.5 | 3.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.5 | 14.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.5 | 9.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.5 | 9.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.5 | 3.3 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.5 | 4.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.5 | 1.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.5 | 5.2 | GO:0019825 | oxygen binding(GO:0019825) |
0.5 | 1.9 | GO:0030984 | kininogen binding(GO:0030984) |
0.5 | 0.5 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.5 | 1.9 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.5 | 0.5 | GO:0045340 | mercury ion binding(GO:0045340) |
0.5 | 1.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.5 | 7.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.5 | 33.8 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.5 | 0.5 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.5 | 1.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.5 | 17.8 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.5 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.5 | 0.9 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.4 | 1.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.4 | 3.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.4 | 8.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 1.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 2.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.4 | 3.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.4 | 1.8 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.4 | 0.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 1.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.4 | 1.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.4 | 1.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.4 | 6.5 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.4 | 5.7 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.4 | 4.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.4 | 0.9 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 2.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.4 | 4.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.4 | 6.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 1.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.4 | 0.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.4 | 2.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 4.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 1.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.4 | 0.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.4 | 3.8 | GO:0048038 | quinone binding(GO:0048038) |
0.4 | 1.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.4 | 0.8 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.4 | 1.7 | GO:0008199 | ferric iron binding(GO:0008199) |
0.4 | 2.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.4 | 3.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.4 | 2.9 | GO:0010181 | FMN binding(GO:0010181) |
0.4 | 5.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.4 | 3.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 2.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 1.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.4 | 0.8 | GO:0035473 | lipase binding(GO:0035473) |
0.4 | 0.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.4 | 1.2 | GO:0055100 | adiponectin binding(GO:0055100) |
0.4 | 8.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.4 | 0.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.4 | 17.8 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.4 | 3.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 10.1 | GO:0015485 | cholesterol binding(GO:0015485) |
0.4 | 2.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.4 | 1.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.4 | 1.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.4 | 2.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 1.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.4 | 2.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.4 | 5.2 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.4 | 1.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.4 | 0.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.4 | 1.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.4 | 0.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 1.6 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.4 | 6.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.4 | 2.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.4 | 2.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.4 | 38.8 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.4 | 1.6 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.4 | 1.2 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.4 | 5.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.4 | 0.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.4 | 1.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.4 | 1.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.4 | 1.2 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.4 | 2.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.4 | 1.9 | GO:0070403 | NAD+ binding(GO:0070403) |
0.4 | 1.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 1.1 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.4 | 1.1 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.4 | 7.6 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.4 | 0.8 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.4 | 0.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.4 | 0.8 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.4 | 10.1 | GO:0050661 | NADP binding(GO:0050661) |
0.4 | 1.5 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.4 | 5.6 | GO:0042805 | actinin binding(GO:0042805) |
0.4 | 23.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 1.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.4 | 2.2 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.4 | 2.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.4 | 0.4 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.4 | 1.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 0.7 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.4 | 1.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.4 | 1.5 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.4 | 2.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.4 | 4.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.4 | 1.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.4 | 1.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.4 | 29.9 | GO:0002020 | protease binding(GO:0002020) |
0.4 | 2.2 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.4 | 0.7 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.4 | 6.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.4 | 1.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.4 | 1.4 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.4 | 0.7 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.4 | 3.6 | GO:0019841 | retinol binding(GO:0019841) |
0.4 | 10.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.4 | 1.8 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.4 | 3.9 | GO:0032183 | SUMO binding(GO:0032183) |
0.4 | 0.4 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.4 | 2.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.4 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.4 | 1.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.4 | 3.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 5.0 | GO:0045296 | cadherin binding(GO:0045296) |
0.4 | 9.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 1.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.4 | 0.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.4 | 1.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 0.7 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.3 | 1.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 14.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.3 | 1.4 | GO:0016918 | retinal binding(GO:0016918) |
0.3 | 14.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.3 | 23.9 | GO:0005178 | integrin binding(GO:0005178) |
0.3 | 1.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 3.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 0.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 0.7 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.3 | 1.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 0.7 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.3 | 1.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.3 | 9.3 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.3 | 0.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 1.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.3 | 1.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 4.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 4.8 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.3 | 1.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 0.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 2.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 1.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 5.3 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 1.7 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 3.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.3 | 3.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 1.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.3 | 0.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.3 | 1.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 2.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 1.6 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 0.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.3 | 1.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.3 | 1.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 3.9 | GO:0043274 | phospholipase binding(GO:0043274) |
0.3 | 1.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 2.6 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 2.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.3 | 1.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 0.6 | GO:0051373 | FATZ binding(GO:0051373) |
0.3 | 3.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 9.9 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.3 | 5.1 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.3 | 1.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.3 | 3.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.3 | 1.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.3 | 1.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 0.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 0.6 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.3 | 0.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.3 | 2.8 | GO:0070628 | proteasome binding(GO:0070628) |
0.3 | 7.8 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 0.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 3.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.3 | 0.3 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.3 | 12.7 | GO:0005518 | collagen binding(GO:0005518) |
0.3 | 0.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 6.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 0.6 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 0.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.3 | 1.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.3 | 1.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 0.9 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.3 | 0.3 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.3 | 2.8 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 6.1 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.3 | 1.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.3 | 0.3 | GO:0032934 | sterol binding(GO:0032934) |
0.3 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.3 | 1.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 7.9 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.3 | 2.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.3 | 2.4 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.3 | 0.6 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.3 | 8.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 1.8 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.3 | 6.3 | GO:0008483 | transaminase activity(GO:0008483) |
0.3 | 219.6 | GO:0008270 | zinc ion binding(GO:0008270) |
0.3 | 3.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 0.3 | GO:0015927 | trehalase activity(GO:0015927) |
0.3 | 3.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 1.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.3 | 1.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 7.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 2.6 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.3 | 2.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 7.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.3 | 0.6 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.3 | 1.7 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.3 | 1.4 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 4.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.3 | 2.8 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.3 | 1.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 0.8 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.3 | 1.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.3 | 1.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 1.1 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 6.1 | GO:0005507 | copper ion binding(GO:0005507) |
0.3 | 0.8 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.3 | 36.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.3 | 0.8 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.3 | 0.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.3 | 0.5 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.3 | 4.6 | GO:0046332 | SMAD binding(GO:0046332) |
0.3 | 0.3 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.3 | 26.2 | GO:0005506 | iron ion binding(GO:0005506) |
0.3 | 0.8 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.3 | 1.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 7.8 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.3 | 0.8 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.3 | 1.9 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.3 | 0.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 2.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 0.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.3 | 1.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.3 | 1.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.3 | 3.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 8.5 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.3 | 0.8 | GO:0001968 | fibronectin binding(GO:0001968) |
0.3 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.3 | 3.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 1.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 0.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 6.5 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.3 | 1.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 2.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 14.0 | GO:0042393 | histone binding(GO:0042393) |
0.3 | 0.3 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.3 | 1.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.3 | 0.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.3 | 0.8 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.3 | 5.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.3 | 9.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.3 | 2.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 0.3 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
0.3 | 0.3 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.3 | 1.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.3 | 10.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.3 | 3.0 | GO:0017069 | snRNA binding(GO:0017069) |
0.3 | 0.8 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.3 | 0.8 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 1.0 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 0.8 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.3 | 3.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 0.2 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.2 | 0.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 30.1 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.2 | 0.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 3.0 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.2 | 10.6 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 66.6 | GO:0019900 | kinase binding(GO:0019900) |
0.2 | 2.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 1.5 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.2 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 0.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 0.7 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.2 | 1.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.2 | 0.2 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.2 | 0.5 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.2 | 0.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.2 | 1.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 0.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 1.4 | GO:0042299 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.2 | 6.4 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.2 | 3.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 2.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.7 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 0.2 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.2 | 0.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 3.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 1.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 0.9 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 13.3 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 0.2 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.2 | 1.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 16.1 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.2 | 9.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.2 | 5.2 | GO:0070736 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.2 | 12.1 | GO:0019902 | phosphatase binding(GO:0019902) |
0.2 | 4.0 | GO:0030145 | manganese ion binding(GO:0030145) |
0.2 | 2.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 1.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 0.4 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.2 | 2.2 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.2 | 1.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 2.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 1.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.2 | 1.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 0.4 | GO:0019961 | interferon binding(GO:0019961) |
0.2 | 0.4 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 1.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 0.4 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.2 | 10.7 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.2 | 0.9 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 0.9 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.2 | 0.6 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 1.3 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 1.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.2 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 1.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 26.2 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 0.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 1.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 0.6 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 3.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 0.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 31.6 | GO:0008134 | transcription factor binding(GO:0008134) |
0.2 | 4.3 | GO:0004527 | exonuclease activity(GO:0004527) |
0.2 | 1.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 0.4 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 10.1 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.2 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 0.6 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.2 | 13.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 6.0 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.2 | 0.8 | GO:0019842 | vitamin binding(GO:0019842) |
0.2 | 0.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 1.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 0.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 3.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 1.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 1.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 3.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 0.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 5.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.2 | GO:0042887 | amide transmembrane transporter activity(GO:0042887) |
0.2 | 0.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.2 | 0.9 | GO:0016454 | C-palmitoyltransferase activity(GO:0016454) |
0.2 | 0.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 1.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 2.4 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 2.2 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.4 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.6 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 0.4 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 4.0 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 0.7 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 0.5 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.2 | 0.4 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 4.1 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 0.7 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 0.9 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 140.5 | GO:0003677 | DNA binding(GO:0003677) |
0.2 | 0.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 0.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 0.5 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 1.7 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.2 | 0.9 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 0.5 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 3.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 0.5 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.2 | 1.2 | GO:0052634 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.2 | 0.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 5.8 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.2 | 0.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.5 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.2 | 0.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.2 | 0.5 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 54.9 | GO:0005198 | structural molecule activity(GO:0005198) |
0.2 | 0.5 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 1.8 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.2 | 1.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.2 | 2.3 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 15.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 1.0 | GO:0034901 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 1.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.6 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.2 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 0.6 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.2 | 0.5 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.2 | 3.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.3 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.5 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.2 | 0.5 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 1.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.6 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 7.9 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.2 | 0.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 0.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 0.3 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 3.5 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.2 | 0.5 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 1.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 1.0 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 1.9 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 3.7 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 0.1 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.1 | 0.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 1.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 4.3 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 2.5 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 1.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 1.0 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.4 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 7.5 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.1 | 0.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.4 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 0.4 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 1.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 3.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.3 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.3 | GO:0005501 | retinoid binding(GO:0005501) |
0.1 | 7.2 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.9 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.3 | GO:0050051 | alkane 1-monooxygenase activity(GO:0018685) leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.1 | 1.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 47.7 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 13.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 15.6 | GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides(GO:0016818) |
0.1 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 29.7 | GO:0016773 | phosphotransferase activity, alcohol group as acceptor(GO:0016773) |
0.1 | 0.5 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 2.5 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.1 | 0.4 | GO:0015491 | cation:cation antiporter activity(GO:0015491) |
0.1 | 0.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.2 | GO:0050544 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.1 | 11.0 | GO:0008289 | lipid binding(GO:0008289) |
0.1 | 0.4 | GO:0004459 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 1.7 | GO:0042562 | hormone binding(GO:0042562) |
0.1 | 0.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 2.1 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.1 | GO:0051379 | epinephrine binding(GO:0051379) |
0.1 | 0.8 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 4.5 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 2.4 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 1.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 2.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.7 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.1 | 0.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 1.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 2.1 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.1 | 0.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.7 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 1.4 | GO:0060090 | binding, bridging(GO:0060090) |
0.1 | 0.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 2.2 | GO:0020037 | heme binding(GO:0020037) |
0.1 | 0.3 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.1 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 1.3 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.1 | 1.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 11.5 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 0.8 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.4 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 0.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.3 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 2.8 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.4 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.1 | 0.1 | GO:0015926 | glucosidase activity(GO:0015926) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.7 | GO:0043176 | amine binding(GO:0043176) |
0.1 | 0.1 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.1 | 0.1 | GO:0046914 | transition metal ion binding(GO:0046914) |
0.1 | 0.7 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 0.2 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 1.3 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 0.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 1.9 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.2 | GO:0008194 | UDP-glycosyltransferase activity(GO:0008194) |
0.1 | 0.6 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 8.5 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.4 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.1 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.1 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
0.1 | 0.1 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.1 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.1 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 3.9 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.1 | 0.1 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 6.2 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 1.6 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.1 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 1.7 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.4 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.1 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.1 | 0.4 | GO:0061135 | endopeptidase regulator activity(GO:0061135) |
0.1 | 0.7 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.3 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 1.0 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.1 | GO:0071813 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.1 | 0.1 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.1 | 0.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 6.7 | GO:0016758 | transferase activity, transferring hexosyl groups(GO:0016758) |
0.1 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 1.2 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 3.8 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.6 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.2 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.1 | 0.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.1 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) ether hydrolase activity(GO:0016803) |
0.1 | 0.2 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.1 | GO:0072341 | modified amino acid binding(GO:0072341) |
0.1 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.1 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.1 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.3 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 7.4 | GO:0017171 | serine-type peptidase activity(GO:0008236) serine hydrolase activity(GO:0017171) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.2 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.9 | GO:0048037 | cofactor binding(GO:0048037) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 1.2 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 4.4 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.3 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.0 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 1.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.0 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.0 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0004953 | icosanoid receptor activity(GO:0004953) prostanoid receptor activity(GO:0004954) |
0.0 | 0.3 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.0 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.1 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.0 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.6 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 4.2 | GO:0032403 | protein complex binding(GO:0032403) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 32.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.0 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.3 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.0 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 4.0 | GO:1901363 | heterocyclic compound binding(GO:1901363) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.0 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.0 | 0.0 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.0 | 0.4 | GO:0016209 | antioxidant activity(GO:0016209) |
0.0 | 0.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 2.0 | GO:0019899 | enzyme binding(GO:0019899) |
0.0 | 0.1 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 1.1 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.1 | GO:0061134 | peptidase regulator activity(GO:0061134) |
0.0 | 0.0 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
0.0 | 0.0 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 16.2 | ST STAT3 PATHWAY | STAT3 Pathway |
1.3 | 10.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.1 | 8.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
1.0 | 33.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.9 | 20.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.9 | 17.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.9 | 12.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.9 | 12.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.8 | 1.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.8 | 21.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.8 | 23.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.8 | 27.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.7 | 12.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.7 | 6.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.7 | 0.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.7 | 20.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.7 | 13.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.7 | 0.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.7 | 23.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.7 | 25.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.6 | 10.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.6 | 0.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.6 | 15.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.6 | 21.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.6 | 26.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.6 | 1.8 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.6 | 13.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.6 | 7.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.6 | 5.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.5 | 14.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.5 | 20.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.5 | 2.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.5 | 7.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.5 | 21.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.5 | 9.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.5 | 12.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.5 | 45.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.5 | 10.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.5 | 7.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.5 | 9.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.5 | 6.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.5 | 5.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.5 | 5.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.5 | 9.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.5 | 2.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.5 | 1.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.5 | 7.0 | PID AURORA A PATHWAY | Aurora A signaling |
0.5 | 4.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.5 | 21.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.5 | 3.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.4 | 1.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.4 | 12.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.4 | 10.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.4 | 8.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.4 | 3.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 4.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.4 | 3.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 10.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.4 | 6.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 10.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.4 | 6.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.4 | 10.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.4 | 6.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.4 | 10.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 3.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 5.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.4 | 2.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.4 | 12.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.3 | 1.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 3.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 4.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 2.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.3 | 4.6 | PID ATM PATHWAY | ATM pathway |
0.3 | 1.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 4.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 1.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 6.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 7.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 2.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 6.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 11.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 3.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 1.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.3 | 0.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 0.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 2.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 7.3 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.3 | 1.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.3 | 1.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.3 | 0.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 1.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 1.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.3 | 1.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 3.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 3.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 0.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 1.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 1.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 5.1 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 1.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 1.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 7.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 2.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 0.9 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 0.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 3.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 0.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 0.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 2.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 0.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 3.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 1.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 1.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 1.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 3.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 2.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 0.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 3.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 2.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 2.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 1.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 4.9 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 2.9 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 2.4 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 1.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 0.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.9 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 21.9 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 0.9 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 25.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 2.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 2.6 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 2.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 21.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 1.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 1.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 0.3 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 1.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 15.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.5 | 10.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.5 | 14.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.2 | 16.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.2 | 19.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.2 | 11.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.2 | 12.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.1 | 17.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.1 | 10.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.0 | 2.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.0 | 1.0 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
1.0 | 9.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.9 | 3.8 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.9 | 1.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.9 | 5.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.9 | 10.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.9 | 11.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.9 | 12.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.9 | 9.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.8 | 6.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.8 | 9.6 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.8 | 4.8 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.8 | 3.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.8 | 2.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.8 | 11.4 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.8 | 16.7 | REACTOME KINESINS | Genes involved in Kinesins |
0.7 | 6.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.7 | 4.5 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.7 | 6.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.7 | 9.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.7 | 13.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.7 | 13.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.7 | 6.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.7 | 12.0 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.7 | 15.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.7 | 1.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.7 | 11.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.7 | 12.5 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.6 | 7.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.6 | 5.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.6 | 7.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.6 | 3.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.6 | 5.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.6 | 7.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.6 | 6.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.6 | 15.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.6 | 13.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.6 | 6.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.6 | 4.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.6 | 9.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.6 | 8.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.6 | 4.6 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.6 | 15.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.6 | 19.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.6 | 8.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.6 | 0.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.6 | 6.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.6 | 9.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.6 | 5.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.6 | 15.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.5 | 4.3 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.5 | 11.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.5 | 5.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.5 | 0.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.5 | 2.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.5 | 10.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.5 | 23.7 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.5 | 15.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 4.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.5 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.5 | 0.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 2.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.5 | 4.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.5 | 11.6 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.5 | 6.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.5 | 7.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.5 | 0.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.5 | 11.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.5 | 12.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.5 | 15.7 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.5 | 2.4 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.5 | 4.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.5 | 1.9 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.5 | 2.9 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.5 | 4.8 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.5 | 39.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.5 | 0.9 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.5 | 0.9 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.5 | 1.8 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.5 | 0.5 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.4 | 0.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.4 | 5.8 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.4 | 3.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.4 | 0.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.4 | 2.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 6.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 3.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.4 | 26.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.4 | 7.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.4 | 7.9 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.4 | 8.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.4 | 0.4 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.4 | 22.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.4 | 0.8 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.4 | 4.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.4 | 16.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.4 | 12.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.4 | 9.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.4 | 2.3 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.4 | 2.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.4 | 5.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.4 | 3.0 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.4 | 4.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.4 | 1.9 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.4 | 0.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.4 | 5.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.4 | 2.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 15.6 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.4 | 1.4 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.4 | 3.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.4 | 0.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.4 | 10.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.4 | 2.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.4 | 17.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.4 | 1.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 1.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.4 | 7.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.3 | 10.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.3 | 15.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 6.9 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.3 | 4.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.3 | 5.8 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.3 | 4.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.3 | 31.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 5.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 0.3 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.3 | 4.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 12.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 8.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.3 | 5.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 4.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 3.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 3.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 1.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.3 | 0.6 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.3 | 11.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.3 | 8.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 6.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.3 | 2.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 4.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 3.2 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.3 | 0.8 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.3 | 16.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 5.6 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.3 | 0.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.3 | 1.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 0.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.3 | 4.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 7.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.3 | 0.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 8.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 0.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.3 | 2.8 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.3 | 0.3 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.3 | 9.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 3.0 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.3 | 2.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 3.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 34.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 2.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 0.7 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.2 | 1.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 5.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 4.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 0.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 19.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 0.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 24.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 0.8 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.2 | 1.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 2.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 1.0 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 1.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 1.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 3.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 1.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 7.8 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 1.2 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.2 | 8.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 0.8 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 1.9 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 0.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 0.2 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.2 | 1.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 0.7 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.2 | 0.2 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.2 | 3.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 3.6 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.2 | 0.7 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
0.2 | 10.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.2 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 0.7 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 1.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 1.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 1.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 2.8 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.2 | 1.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 8.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 1.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 0.5 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 4.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 2.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 6.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 1.9 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 0.4 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 1.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.7 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.4 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 1.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.7 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 12.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 1.0 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.4 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 1.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 1.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 1.6 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 2.2 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 1.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 2.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 2.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 0.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 0.5 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.1 | 2.0 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 1.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 0.3 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.1 | 0.8 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 0.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.2 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 2.0 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 0.3 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 0.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 1.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.9 | REACTOME MAP KINASE ACTIVATION IN TLR CASCADE | Genes involved in MAP kinase activation in TLR cascade |
0.0 | 1.4 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.2 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.0 | 0.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.0 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |